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ABSTRACT 
 
 Three experiments were conducted with the purpose of re-evaluating the vitamin 
D3 requirement of growing chickens. Due to intense genetic selection in the poultry 
industry, it is probable that modern strains have altered their nutritional requirements. 
Therefore, it is necessary to re-evaluate their ability to respond to modern feeding 
strategies. In the first experiment, broiler chickens were obtained from different 
commercial hatcheries and fed a basal vitamin D3-deficient starter diet with the objective 
of evaluating the variability in maternal deposition of vitamin D3 in the egg yolk. No 
significant (p>0.05) differences were found in the initial serum concentrations of 25-
hydroxycalciferol (25-OH-D3) within sources of broiler chickens. Maternal vitamin D 
reserves will deplete around day 10 regardless of the initial concentration in newly 
hatched chickens. In the second experiment, 500 Ross-308 broiler chickens were 
sampled after being fed with 3,850 IU/kg cholecalciferol (D3) or 3,850 IU/kg D3 plus 
one of two sources of 25-OH-D3 for a 24-h period at different time points to evaluate the 
dynamics of serum 25-OH-D3, and identify if there was any “circadian-type” trend in the 
broiler´s response to dietary 25-OH-D3 over time, as well as identify important 
information about the effect of age in the metabolism of 25-OH-D3 and bone ash 
mineralization. Both sources showed a significant linear increase in serum 25-OH-D3 
concentrations (p<0.05) over the 24-h exposure to treatment diets. Finally, for the third 
experiment, 96 Hy-line chickens were placed in a very controlled environment and a 
concentrated liquid form of vitamin D3 (Pure Life® Labs) was directly gavaged in 
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precise increasing amounts to re-evaluate the requirement of this metabolite for growth 
performance and bone mineralization. The estimated requirement for growing leghorn 
chickens was 800 IU/kg D3 for maximum growth and bone mineralization. Results of 
these studies show that in order to produce a vitamin D3-deficient status in young broiler 
chickens, it is necessary to have strict control on the breeder’s diet. The supplementation 
of 25-OH-D3 increases the probability of maximum biological function with regard 
vitamin D. The re-evaluation of the vitamin D3 requirement for leghorn chickens 
suggests that the NRC (1994) minimum vitamin D3 requirement of 200 IU/kg might be 
inadequate for modern poultry leghorn strains. 
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1. INTRODUCTION  
 
 Genetic selection in meat-type chickens over the past 20 years have led to 
increased productivity, thanks to the improvement in growth potential and feed 
efficiency. This was shown by Havenstein et al. (2003) when they compared two strains 
of broilers; Athens-Canadian Randombred Control (ACRBC) and the 2001 Ross-308 and 
fed representative 1957 and 2001 diets, respectively. They found that the Ross-308 
broilers on the 2001 feed were estimated to have reached 1,815 g body weight (BW) at 
32 days of age with a feed conversion (FC) of 1.47; whereas, the ACRBC on the 1957 
feed would not have reached that BW until 101 days of age with a FC of 4.42. Because 
feed represents up to 70% of the total production costs, the opportunity to evaluate birds 
ability to respond to different extents of nutrient density and new alternative ingredients 
have become one of the main concerns in the poultry industry to reduce the cost of feed. 
One consequence of the improvement in growth rate (35-50 g yearly increase in 
42-49 day BW; Leeson and Summers, 2005) is leg health, which is an important 
component of broiler welfare, and therefore, in general broiler performance. Leg health 
encompasses a wide range of leg disorders leading to locomotion problems and high 
mortality (Kapell et al. 2012) which represents a major economic issue for the poultry 
industry. Sullivan (1994) estimated annual losses in the United States due to skeletal 
problems in broiler production around $80 to $120 million USD which adjusted to the 
annual inflation (U.S. Bureau of Labor Statistics) would represent $ 128,000,000 to 
192,000,000 USD in 2014.  
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 Common leg problems in rapid growth rate strains include tibial 
dyschondroplasia (TD), angular bone deformities, such as medial deviation of the distal 
tibia or proximal metatarsus, and rickets (Waldenstedt, 2006). Vitamin D is a term 
associated with a group of related steroid chemical compounds that possess antirachitic 
activity. There are two common forms, ergocalciferol (D2) and cholecalciferol (D3). 
Since D2 has about 10% the bioactivity of D3 for poultry (McDonald et al. 1995) D3 is 
used to supplement poultry feeds. The main role of vitamin D is the control of bone 
development through its ability to strictly regulate Ca absorption (Aslam et al., 1998). 
Therefore, vitamin D has a strong relationship with calcium (Ca) and phosphorus (P) 
metabolism and ultimately bone health. The quantitative requirement of growing 
chickens for vitamin D is usually based on functional assessments using measurements 
of bone quality, such as bone ash content or incidence of rickets, which have been found 
to be more sensitive indicators of requirements than growth rate (Waldroup et al., 1963, 
Edwards et al., 1994). The vitamin D requirement reported by the NRC (1994) is 5 µg/kg 
(200 IU/kg) for both growing broilers and leghorn strains. Seventeen years ago, Baker et 
al. (1998) reported in agreement with the NRC (1994) that 5 µg/kg (200 IU/kg) appeared 
to be adequate for maximal weight gain and bone ash in broiler chickens from 8-20 days 
post hatching when fed adequate levels of available P. However, changes in available P 
can increase the requirement up to 37.5 µg/kg (1,500 IU/kg). More recent studies 
reported higher requirements for vitamin D; Kasim and Edwards (2000) estimated the 
vitamin D requirement for broiler chickens was 25 µg/kg (1,000 IU/kg). Fritts et al. 
(2003) reported that approximately 50 µg/kg (2,000 IU/kg) of vitamin D3 was needed for 
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maximum bone ash in 21-day-old broilers. Whitehead et al. (2004) showed that vitamin 
D3 requirements of broilers up to 14 days of age at sufficient dietary Ca and available P 
concentrations may be in the range 35-50 µg/kg (1,400-2,000 IU/kg) of feed for optimal 
cortical bone quality. Khan et al. (2010) concluded that performance, bone 
mineralization and immunity were significantly improved when supplementing high 
levels of vitamin D3 [37.5-87.5 µg/kg (1,500-3500 IU/kg)] in broiler diets compared with 
the NRC requirement. Baird et al. (1935) estimated the vitamin D3 requirement for 
growing brown egg layers to be 4.5 µg/kg (180 IU/kg). Thus, there is a big debate 
regarding the vitamin D requirement of growing chickens, as some authors (Baker et al., 
1998, Fowler et al. 2014) agree with the NRC (1994) requirements. However, a number 
of studies made post 1994 suggest higher doses are needed to support rapid growth of 
modern poultry strains and prevent the appearance of leg disorders such as TD (Kasim 
and Edwards, 2000, Ledwaba and Roberson, 2003, Whitehead et al. 2004, Khan et al., 
2010).  
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The nutritional importance of vitamin D is not limited to Ca and P metabolism in bone 
mineralization. Other functions of vitamin D include stimulation of intestinal absorption 
of Ca and P, maintaining normal parathyroid hormone concentration, mediating kidney 
Ca reabsorption and influencing diverse immune functions (De Luca, 2004) such as cell-
mediated and humoral antibody response. A deficiency in vitamin D can increase the 
susceptibility to infections due to impaired localized innate immunity and defects in 
antigen-specific cellular immune response (Wintergerst et al. 2007). 
  The aim of this thesis project is to re-evaluate the vitamin D3 requirement in the 
growing chicken by tracking the maternal deposition of vitamin D3 in the egg yolk and 
the dynamics of 25-hydroxycholecalciferol (25-OH-D3) concentration in the blood.  
This information will be used to establish an accurate procedure to test the requirement in 
growing chickens using an individual daily oral dose of a liquid form of pure 
cholecalciferol to have precise control in vitamin D3 consumption.  
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2. LITERATURE REVIEW 
 
2.1 HISTORY OF VITAMIN D 
 The history of vitamin D has been reviewed by Norman (1979), De Luca (2004) 
and Combs (2012). As with most of the known vitamins, their discovery is usually 
related or linked with common diseases or disorders that were observed in animals or 
humans at different stages of history. The first approach to vitamin D study was made in 
the times of ancient Greece when Hippocrates pointed out the importance of sunlight in 
human health and described conditions that resembled rickets (Mohr, 2009). The first 
descriptions of rickets were written by Daniel Whistler who wrote on the subject in his 
medical thesis at Oxford University in 1645 and Professor Francis Glisson of London 
who also wrote about the subject in 1650. The formal study of vitamin D started in the 
eighteenth century when rickets were accepted as a skeletal disorder and a health 
problem, especially during the industrial revolution in England where rickets were 
known as “The English Disease.” Sbiadecki (1822) suggested that rickets were caused by 
lack of exposure to sunlight, when he compared the incidence between children that lived 
in urban and rural areas. The first description of the rachitic skeleton was made by 
Pommer in 1885. Palm (1980) pointed out the importance of sunlight to prevent rickets. 
Many factors were described as responsible for rickets: lack of fresh air, congenital 
factors, age, infectious agents and lack of physical activity were examples of some of 
these factors. At the same time vitamin A was recognized to prevent xeropthalmia and 
night blindness and was identified to be present in cod liver oil. In 1919, Edward 
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Mellanby undertook the studies of vitamin A and tried to develop a dietary model for 
rickets.  He conducted several studies where he fed dogs a low-fat diet, and when he 
observed that the dogs developed rickets, he concluded that rickets were probably also 
due to a vitamin A deficiency and that cod liver oil was an excellent antirachitic agent; he 
also established the importance of dietary Ca and P in preventing rickets. However, 
McCollum (1922) who previously identified vitamin A, was convinced that this new 
antirachitic activity of cod liver oil was due to a different compound. After he bubbled 
oxygen through heated cod liver oil to destroy the vitamin A, he fed the oil to rats and 
chicks and found that the processed oil was still able to cure rickets. He concluded that a 
different compound was responsible for reducing the incidence of rickets, and he called it 
vitamin D. Goldblatt and Soames (1923) demonstrated that UV-irradiated rat livers that 
were fed to rachitic rats were able to cure rickets. Steenbock and Black (1924) also found 
that UV-irradiated food was also able to cure rickets in rachitic rats. Thus, the first 
relationship between light and vitamin D was formally established. The vitamin D3 
chemical structure was determined by Windaus´s group in 1936. It wasn´t until the 
1970´s that Kodicek et al. (1970), DeLuca (1978) and Norman (1979) clearly defined the 
vitamin D metabolites and their controls. 
2.2 PROPERTIES AND METABOLITES OF VITAMIN D3 
 Vitamin D, also known as the “sunshine vitamin,” is a fat-soluble vitamin that 
encompasses a group of steroid chemical compounds that possess antirachitic activity. 
Vitamin D3 is soluble in organic non-polar solvents and oils; it has a melting point of 84-
85°C and can be destroyed by excess irradiation of UV-light and peroxidation when 
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rancidifying polyunsaturated fatty acids are present.  The use of some antioxidants such 
as vitamin E may prevent vitamin D destruction (Leeson and Summers, 2001). The most 
common forms of vitamin D are ergocalciferol (D2) and cholecalciferol (D3). Vitamins 
D2 and D3 have relatively the same potency for cattle, sheep and pigs, but D2 has only 3% 
of the potency of D3 for poultry (Leeson and Summers, 2001). Chen and Bosmann 
(1964) in a very controlled study using crystalline vitamins D2 and D3 reported an 
antirachitic activity ratio from 1:8 to 1:11 in poultry, respectively. One unit of vitamin D3 
[International Units (IU)] is defined as the activity of 0.025 µg of cholecalciferol (NRC, 
1994). 
 Cholecalciferol is produced in vivo by irradiation of the provitamin D3 7-
dehydrocholesterol, in the epidermal layer of the skin where, by exposure to the 
ultraviolet light (290-310 nm) either from the sun or an artificial source, it is synthesized 
to cholecalciferol (Combs, 2012). The structures of vitamin D3 and D2 are shown in 
Figure 1. The precursors of vitamin D3 have no effect in the body until the B-ring is 
opened between the 9 and 10 positions of the steroid. This occurs with ultraviolet 
irradiation forming a double bond between the carbon atoms at the 10 and 19 positions of 
the new compounds (Leeson and Summers, 2001). It has been found that ten times more 
provitamin D3 is present in the featherless leg skin than on the back, indicating the 
importance of this area for vitamin D3 metabolism (Tian et al. 1994). The synthesized 
cholecalciferol, formed in the skin, is absorbed and transported via the blood to the liver 
where it is converted to 25-hydroxycholecalciferol (25-HO-D3), the major circulating 
form of vitamin D3. The level of 25-OH-D3 associated with adequate bone health is 30 
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ng/ml, and this is parameter is considered to be the best indicator of vitamin D status 
(Pettifor et al., 1977). The half-life of 25-OH-D3 is 20 days (Combs, 2012). The 25-OH-
D3 must be transported to the kidneys for conversion into 1,25-dihydroxycholecalciferol 
(1,25(OH)2 D3) which is the active hormonal metabolite of the vitamin (Norman, 1979). 
The newly formed 1, 25(OH)2 D3 is transported via the blood to the intestine, bones, or 
anywhere else required to perform its metabolic function. Transport of cholecalciferol 
and metabolites is possible thanks to the vitamin D binding protein (DBP) which binds to 
the metabolites from the skin and dietary sources. The production of 1, 25(OH)2 D3 is 
regulated by parathyroid hormone (PTH) in response to Ca and P concentration in the 
blood. When the concentration of Ca in blood is low, PTH is secreted, and the kidneys 
react by releasing P into urine; this metabolic change stimulates the kidney to produce 1, 
25(OH)2 D3. If Ca and P levels are normal, the kidney transforms 25-OH-D3 into 1, 24, 
25-trihydroxyvitamin D3 an analog of vitamin D (Leeson and Summers, 2001). Holick et 
al. (1973) found that this analog 1, 24, 25-trihydroxyvitamin D3 was less bioactive 
(around 60%) than 1, 25(OH)2 D3 in stimulating intestinal Ca absorption and bone Ca 
mobilization.  
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Figure 1. Chemical structures of cholecalciferol (D3) and ergocalciferol (D2). 
Structures drawn using ChemDraw® Professional 15.0 software.  
 
 
2.3 ABSORPTION AND TRANSPORT 
 The absorption of vitamin D through the intestine is classified as micelle 
dependent passive diffusion and requires the presence of bile salts that help in the 
formation of micelle structures in the small intestine. The major absorption of vitamin D 
occurs in the distal part of the jejunum and ileum (Combs, 2012, Goncalves, 2015).  
Once it reaches the blood stream, vitamin D is rapidly distributed throughout the body, 
where the highest concentration will be found in the intestine, liver, kidneys, and spleen 
(Leeson and Summers, 2001).  Vitamin D and its metabolites will be transported within 
the body with the help of the vitamin D binding protein (DBP) which binds the vitamin 
stoichiometrically.  Also, endogenous vitamin D produced in the skin will be transported 
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into the blood stream with the help of DBP (Combs, 2012). Excretion of vitamin D is 
primarily through the feces with very little excretion in the urine (McDowell, 1989). 
2.4 METABOLIC FUNCTIONS 
 Vitamin D supports bone growth and mineralization indirectly by elevating Ca 
and P levels in the plasma to a point necessary to support normal body functions 
(Underwood and DeLuca, 1984). Two hormones, thyrocalcitonin (calcitonin) and 
parathyroid hormone (PTH) have influence on the release of 1,25(OH)2D3, and are 
needed to control levels of blood Ca and P. The role of calcitonin appears most important 
in controlling high serum Ca levels by depressing gut absorption, halting bone 
demineralization and depressing Ca absorption in the kidney. On the other hand, vitamin 
D3 elevates plasma Ca and P by stimulating specific pump mechanisms in the intestine, 
kidney and bone, thus maintaining blood levels of Ca and P, from these body reserves 
(Leeson and Summers, 2001). The synthesis of 1,25(OH)2D3 is tightly regulated by PTH, 
depending on the calcium status of the bird. Normal Ca concentration in blood is around 
10 mg/dL. The D3 metabolite 1,25(OH)2D3 stimulates  the expression of the calbindin-
D28K-mRNA gene in the intestinal wall (Hall and Norman, 1990) and induces the 
synthesis of calcium binding protein calbindin-D28K . Theofan et al. (1986) measure the 
intestinal transcription level of calbindin-D28K-mRNA in vitamin D3 depleted white 
Leghorn cockerels treated with an intramuscular dose of 1,25(OH)2D3.  He concluded 
that the transcription of the calbindin-D28K-mRNA gene is directly correlated to nuclear 
uptake and binding of 1,25(OH)2D3 to its receptor. The presence of this protein reflects 
the ability of the intestine to absorb Ca by facilitating the movement of calcium through 
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the enterocytic cytosol while keeping the intracellular concentration of the free Ca ion 
below hazardous levels (Combs, 2012). Calcium binding protein calbindin-D28K is 
virtually not expressed in the intestine during vitamin D deficiency, but is expressed in 
response to 1,25(OH)2D3 supplementation (Theofan et al., 1986, Meyer et al., 1992). 
Bone formation is stimulated by 1,25(OH)2D3, which induces osteoclastin production 
from osteoblasts (Standford, 2006). The ability to release Ca from the bones is vital for 
maintaining constant levels of Ca in the blood. Bone is a dynamic tissue that is 
constantly remodeled. In healthy individuals with adequate physiological functions bone 
resorption and formation are tightly balanced (Norman and Hurwitz, 1993). Intestinal P 
absorption is also favored by the 1,25(OH)2D3  metabolite action which  stimulates the 
Na
+
/P co-transport in the intestine which is necessary to transport P through the intestinal 
wall (Combs, 2012). Vitamin D is also involved in Ca and P resorption in the renal tubes 
of the kidney to maintain general homeostasis in the body (Norman, 1979). 
 Evidence also suggests that vitamin D3 plays a regulatory role in immune cell 
function (De Luca, 2004). This was also reported by Aslam et al. (1998) who found that 
broiler starter diets without supplemental vitamin D3 depresses the cellular immune 
responses in young chicks by reducing the number of abdominal macrophages. Cantorna 
(2006) studied autoimmune disorders in mice and found that vitamin D had a positive 
effect in the regulation of T cell development and function which will decrease the 
susceptibility of autoimmune diseases such as multiple sclerosis and inflammatory bowel 
disease. Wintergerst et al. (2007) found that a deficiency in vitamin D can increase the 
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susceptibility to infections due to impaired localized innate immunity and defects in 
antigen-specific cellular immune response.  
2.5 NUTRITIONAL REQUIREMENT FOR GROWING CHICKENS 
 Many factors influence the vitamin D3 requirement of the chicken such as the 
source of P in the diet, the ratio of Ca to P and the extent of exposure of the animal to 
sunlight. There are a number of reports indicating that 11 to 45 minutes exposure to 
sunlight per day is sufficient to prevent rickets in growing chickens (Leeson and 
Summers, 2001).  The vitamin D3 requirement for starting leghorns and broiler strains 
reported by the NRC (1994) is 5 µg/kg (200 IU/kg). Baker et al. (1998) reported, in 
agreement with the NRC (1994), that 5 µg/kg (200 IU/kg) appeared to be adequate for 
maximal weight gain and bone ash in broiler chickens from 8-20 days post hatching 
when fed adequate levels of available P. However, changes in available P can increase 
the requirement up to 37.5 µg/kg (1,500 IU/kg). Baird et al. (1935) estimated the vitamin 
D3 requirement for brown egg layers to be 4.5 µg/kg (180 IU/kg). Years later, several 
studies reported different requirements. Kasim and Edwards (2000) estimated the 
cholecalciferol requirement for growing broiler chickens ranged from 20.1 to 28.3 µg/kg 
(804-1,131 IU/kg). Fritts et al. (2003) reported that approximately 50 µg/kg (2,000 
IU/kg) of vitamin D3 was need for maximum bone ash in 21 day old broilers. Ledwaba 
and Roberson (2003) found that approximately 40-45 µg/kg (1,600-1800 IU/kg) D3 was 
required to reduce rickets in male broiler chicks fed a vitamin D3-deficient diet. 
Whitehead et al. (2004) showed that vitamin D3 requirements of broilers up to 14 days of 
age at sufficient dietary Ca and available P concentrations may be in the range 35-50 
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µg/kg (1,400-2,000 IU/kg) of feed based on maximum cortical bone quality. Rao et al. 
(2006) concluded that performance and bone mineralization in broilers could be 
maintained with suboptimal concentration of Ca and P (0.5 and 0.25 % respectively) with 
high concentrations of vitamin D3 [90 µg/kg (3,600 IU/kg)] in the diet. Khan et al. (2010) 
concluded that performance, bone mineralization and lymphoid organ weight/body 
weight ratio was significantly improved when supplementing high levels of vitamin D3 at 
37.5-87.5 µg/kg (1,500-3,500 IU/kg) in broiler diets when compared with the NRC 
(1994) requirement. As the ratio of Ca to available P becomes narrower, the requirement 
for vitamin D3 increases (Leeson and Summers, 2001). Also, the requirement becomes 
higher if the source of P in the diet is of low availability. Mycotoxins may also 
significantly increase the requirement of vitamin D3, possibly due to impaired absorption 
and liver functions (Leeson and Summers, 2001). Driver et al. (2006) studied the effect 
of maternal dietary vitamin D3 and found that hens fed 50 µg/kg (2,000 IU/kg) vitamin 
D3 of were able to deposit sufficient quantities of vitamin D3 in the egg to maintain 
excellent 16-day BW of chickens and reduce the incidence and severity of TD when fed 
a TD-inducing diet. Recent literature suggesting higher requirements for vitamin D3 
presume this to be due to changes in metabolism of the rapid growth modern poultry 
strains.  
2.5.1 Deficiency symptoms 
 The most evident signs of vitamin D3 deficiency are rickets, TD, osteomalacia in 
adults and retarded growth. Also beaks and claws will become soft and pliable. 
Feathering is usually poor and other structural disorders may be noted such as a bent 
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spinal column and sternum deviated (Leeson and Summers, 2001). Lofton and Soares 
(1986) studied the effects of vitamin D3 on leg abnormalities in broilers that were fed less 
than 5 µg/kg (200 IU/kg) of diet and found significantly lower body weights, feed 
efficiency values, serum ionic calcium, total serum calcium, tibial breaking strength, and 
percentage tibial ash values. In addition, Aslam et al. (1998) found in vitamin D-deficient 
chicks a reduction in the cellular immune response and a reduction in thymus weight. 
Also, Sunde et al. (1978) studied the effect of different D3 metabolites in embryo 
development and found that deficient vitamin D diets led to defective upper mandibles 
and high mortality during the first two weeks of age.  
2.5.2 Toxicity 
 Excessive intakes of vitamin D3 also have negative effects, and most common 
signs of toxicity are related to abnormal high blood Ca concentration, known as 
hypercalcemia, and low levels of PTH that ultimately affect bone health (McDowell 
1989). Cruickshank and Sim (1987) reported that excessive supplementation of vitamin 
D3 100 µg/kg (4,000 IU/kg) combined with high stocking density may increase the 
incidence of twisted leg and negatively affect the feed conversion ratio. Leeson and 
Summers (2001) stated that high D3 in poultry diets produces a syndrome characterized 
by resorption of bone salts and abnormal deposition of calcium in the viscera and soft 
tissues in growing chickens. Excessive D3 can lead to renal damage, due to calcification 
of the kidney tubules while the aorta and other arteries may also become calcified. Nain 
et al. (2007) found that broilers fed excessive amounts of vitamin D3 2,000 µg/kg 
(80,000 IU/kg) were more susceptible to sudden death syndrome associated with a higher 
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rate of cardiac arrhythmia with respect to broilers fed 125 µg/kg (5,000 IU/kg). 
Estimated safe upper intake levels of D3 are presented in Table 1. Other toxicity signs 
may include anorexia, gastrointestinal distress, lameness and calcinosis (Combs, 2012). 
 
 
Table 1. Estimated safe upper intake levels of vitamin D3 (IU/kg) 
Animal 
Exposure time 
< 60days > 60 days 
Chicken 40,000 2,800 
Turkey 90,000 3,500 
Japanese quail 120,000 4,700 
Adapted from NRC (1987) 
 
 
2.6 SOURCES OF VITAMIN D 
 Ergocalciferol is widely distributed in plants, fungi and molds while 
cholecalciferol is present in animals where vitamin concentration depends on the dietary 
vitamin D3 and exposure of the tissue to sunlight (Combs, 2012). Sources of vitamin D 
are natural foods like milk, butter, veal, beef and vegetable oils; irradiated sebaceous 
material licked from skin or hair or directly absorbed products of irradiation formed on or 
in the skin. (McDowell, 1989). Some natural sources of vitamin D2 or D3 and estimated 
concentrations are presented in Table 2. 
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Table 2. Concentration of vitamin D in common foods and feedstuffs 
Food /Feed Stuff IU/100g 
 Ergocalciferol (D2) 
Alfalfa, sun cured 142 
Alfalfa silage 12 
Corn grain 0 
Corn oil 9 
Corn silage 13 
Molasses 58 
Sorghum grain 2.6 
Spinach 0.2 
 Cholecalciferol (D3) 
Cod liver oil 10,000 
Menhaden entire body oil 5,000 
Blue fin tuna liver oil 4,000,000 
Eggs 100 
Beef Liver 8-40 
Chicken Liver 50-65 
Cow milk 4 
Adapted from McDowell (1989) and Combs (2012) 
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3. MODELING MATERNAL VITAMIN D3 IN BROILER CHICKENS 
 
3.1 INTRODUCTION 
 Multiple factors influence the concentration of nutrients in the egg yolk. The age 
of the breeders, diet composition and nutrient density, housing conditions or general 
management can result in different maternal deposition of nutrients and specifically of 
vitamin D3. Moran (2007) studied the effect of maternal deposition of nutrients in the egg 
yolk and found that any nutritional inadequacies in the parental flock will had a negative 
impact on the performance of the resulting chicks. An adequate nutrition of the breeder 
flock is vital to ensure good development and hatchability of the embryos; both excess 
and deficient nutrient density leads to poor performance and viability of the young 
chickens (Wilson, 1997). It is known that in the poultry industry high amounts of vitamin 
D3 are fed to breeders, which leads to a high deposition of this fat-soluble vitamin in the 
egg yolk. All things being equal, once a chick is hatched, its viability will be closely 
related to the nutritional reserves from the yolk stores that were used as the primary 
nutrient source during the time spent adapting to a solid diet. Dietary vitamin D3 in the 
breeder flock will affect egg shell thickness, egg production and egg mass that ultimately 
will affect performance of the progeny (Coto et al. 2010a) 
 Previous research done in our laboratory has found a high variability in response 
to dietary vitamin D3. In some cases, it can be difficult to find a significant decrease in 
percentage bone ash as an indicator of the vitamin D activity in young broilers. The data 
collected from our laboratory suggest that the maternal vitamin D3 in egg yolk may be 
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sufficient to sustain growth and the mineralization of bones, even when they were fed a 
vitamin D3-deficient diet. The objective of this study was to model the maternal 
deposition of vitamin D in the egg yolk, comparing chickens from different commercial 
hatcheries and correlating this with the mineralization of bones and serum 25-OH-D3 
concentration during the first few weeks of age. 
3.2 MATERIALS AND METHODS 
3.2.1 Experimental design overview 
        Three experiments were conducted using newly hatch broiler chickens obtained at 
different dates from two commercial hatcheries. For the first experiment, broiler chickens 
were obtained from Sanderson Farms (Bryan, TX) and placed in a Petersime battery 
brooder. A basal vitamin D3 deficient corn-soy broiler starter diet was formulated and 
served as a negative control (NC1) during the entire trial to control for residual maternal 
D3 stores from the yolk. From the same basal diet a batch was separated and 
supplemented with 3,850 IU/kg cholecalciferol and served as the positive control (PC).  
For the second and third experiment, broiler chickens were obtained from the Cobb 
hatchery (Timpson, TX) and from Sanderson Farms (Bryan, TX), respectively, and placed 
in a Petersime battery brooder.  Only, the vitamin D3-deficient diet previously used in 
experiment 1, was fed to the broiler chickens for both trials (NC2 and NC3).  
For the three experiments, minimal lighting was maintained in the rearing room to 
reduce endogenous synthesis of cholecalciferol. This was achieved by removing all 
lateral lamps in the room and by covering completely the roof lamps with brown paper.  
Blood samples were taken from at least 2 birds from each treatment every 2 days to be 
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analyzed for 25-OH-D3 concentration using a commercial ELISA Kit (25-OH-Vitamin D 
Kit, Eagle Biosciences®). Tibia samples were also taken every 2 days from the same 
birds for bone ash determination to evaluate the vitamin D3 activity.  
3.2.2 Housing and daily observations 
 Birds were caged in one Petersime battery brooder located in an environmentally 
controlled rearing room (# 1215) at the Texas A&M Poultry Research Farm. Minimal 
lighting (as previously described) in the room was provided on a constant 24-h basis. The 
complete absence of UV light in the rearing rooms has been verified previously (Fowler 
et al. 2014). Birds were observed daily with regard to general flock condition, 
temperature, lighting, water, feed, and unanticipated events for the rearing facility.  
3.2.3 Experimental subjects 
 Broiler chickens were obtained from two different commercial hatcheries; Ross-
308 broilers from Sanderson Farms (Bryan, TX) or Cobb-500 from the Cobb hatchery 
(Timpson, TX).  
3.2.4 Dietary treatments 
          A basal corn-soy vitamin D3-deficient broiler starter diet was formulated; this was 
achieved by using a customized mineral/vitamin premix without vitamin D3 and utilizing 
corn oil as the fat source (Table 3).  This basal diet was subdivided into two batches. One 
batch was supplemented with 3,850 IU/kg cholecalciferol (PC) and the other was fed 
without any supplemental vitamin D3 and served as a negative control (NC). Feed and 
water was offered ad libitum.  
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Table 3. Broiler starter experimental basal vitamin D deficient diet
1
 
Ingredient % 
Corn 61.34 
Dehulled soybean meal 32.19 
DL-Methionine 0.23 
L-Lysine HCl 0.18 
Corn oil 2.31 
Limestone 1.44 
Monocalcium phosphate 1.55 
Salt 0.55 
Custom vitamin/mineral premix
2
 0.5* 
1
Calculated nutritional content was as follow: crude protein 22%, metabolizable energy 3050 
kcal/kg, calcium 0.95 %, available phosphorus 0.45 %, methionine 0.56 %, methionine+cystine 
0.92 %, lysine 1.31%, tryptophan 0.20 %, threonine 0.82% arginine 1.46%, crude fat 4.17% and 
crude fiber 2.15% 
2*
Vitamin/mineral premix guaranteed analysis: Copper 2200ppm, Iodine 400 ppm, Iron 4,000 
ppm, Manganese 2.5%, Zinc 2.5%, Selenium  40 ppm, vitamin A 1,596,650 IU/kg and vitamin E 
7,964 IU/kg. Recommended inclusion level 5 kg/t to manufacture complete poultry feed. 
 
 
3.2.5 Sera samples 
         Blood was drawn from at least 2 birds every 2 days and collected within 
Eppendorf® 1.5 ml tubes and centrifuged at 3000 xg for 10 min to separate the serum 
which then was used to run a commercial ELISA Kit (25-OH-Vitamin D Kit Eagle 
Biosciences®). The assay procedure was done following the user’s manual from the kit.  
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3.2.6 Bone ash determination 
         The left tibia was dissected from the same birds selected to draw blood for bone ash 
determination to evaluate vitamin D3 activity. Muscle and cartilage were removed before 
being placed in 4 L of petroleum ether for 48 h at room temperature. Following this, 
tibias were dried for 24 h in a drying oven at 105°C. Finally tibias were ashed at 650°C 
for 23 h. Ash was evaluated as a percentage of the free-fat, dried bone weight. 
3.2.7 Statistical analysis 
         The serum 25-OH-D3 concentration data were subjected to repeated measures 
analysis using the GLM procedure of SPSS. Dietary treatments were used as fixed factor. 
Means were separated by Duncan´s multiple range test. Statistical significance was 
accepted at p≤0.05. Broken-line regression was used to analyze the percentage bone ash 
data using the “Nutritional Response Model Program” Version 1.01 from Gene Pesti and 
Dmitry Vedenov, University of Georgia. Individual birds served as the experimental unit 
for bone ash data analysis. 
3.3 RESULTS 
3.3.1 Maternal vitamin D3 status  
           Experiment 1. After 21 days on the treatment diets a significant (p<0.05) 
difference between NC and PC was observed on days 7, 9, 11, 15 17 and 21 (Table 4), 
suggesting that on day 7 the maternal reserves of vitamin D3 were considerably depleted. 
The lowest serum concentration of 25-OH-D3 was reached at day 11 for the NC1. Even 
when there was no statistical difference on day 13 and 19 a clear numerical difference 
was found between treatments following the depletion trend observed on day 7.   
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Table 4. Experiment 1  ANOVA serum 25-OH-D3 (ng/ml)  
 
Day 
Exp 1 
NC1 PC 
1 26.18±7.67 27.39±1.02 
3 7.98±9.45 18.67±6.25 
5 6.53±0.70 21.65±7.51 
7 3.91±1.00
b
 20.97±0.01
a
 
9 3.70±0.48
b
 17.16±4.49
a
 
11 3.39±2.75
b
 23.06±1.42
a
 
13 5.90±1.66 26.22±10.93 
15 5.66±3.81
b
 31.19±2.02
a
 
17 5.08±2.48
b
 35.04±0.35
a
 
19 4.15±4.38 32.10±11.34 
21 13.03±0.43
b
 38.93±7.44
a
 
a,b Means within a row with no common superscript differ significantly (P<0.05). 
± Standard deviation. n= 2 birds per day. Exp 1 Sanderson Farms (Bryan, TX). 
 
 
           The distribution of serum 25-OH-D3 concentrations for experiment 1 are 
presented in Figure 2, where a clear difference is observed in the trends of NC1 and PC1 
throughout time.  
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Figure 2. Maternal 25-OH-D3 (mg/ml) trend NC1 vs PC1 Exp 1 Sanderson Farms (Bryan, TX). 
 
 
Experiments 1-3. No difference (p>0.05) was found between flocks throughout 11 
days on the vitamin D3-deficient diet. Only on day 7 a significant difference was found, 
NC1 had higher serum 25-OH-D3 values than NC2 and NC3 (Table 5).  Data suggest that 
regardless of initial maternal reserves of vitamin D3 the chickens will deplete at a similar 
rate (Figure 3). 
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Table 5. Flock variability ANOVA serum 25-OH-D3 (ng/ml)  
Day 
Experiment  
NC1
1*
 NC2
2**
 NC3
2*
 
1 26.18±7.67 27.30±2.64 33.11±4.5 
3 7.98±9.45 18.33±1.31 15.82±7.32 
5 6.53±0.70 5.60±4.13 3.43±3.06 
7 3.91±1.00
a
 1.36±1.26
b
 0.21±0.36
b
 
9 3.70±0.48 4.62±3.75 8.76±1.66 
11 3.39±2.75 3.53±2.63 9.57±4.35 
a,b Means within a row with no common superscript differ significantly (P<0.05). 
± Standard deviation. 
1 
n= 2 birds per day    
2
 n= 3 birds per day. * Sanderson Farms (Bryan, TX) 
** Cobb hatchery (Timpson, TX). 
 
 
 
Figure 3. Maternal 25-OH-D3 trend variability between broiler sources (ng/ml).  
S1=Sanderson Farms (Bryan, TX) S2=Cobb hatchery (Timpson, TX). 
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3.3.2 Bone ash 
The percentage bone ash for each of the NC treatments and the PC from the first 
experiment is presented on Figures 4-7. The breaking point in the linear ascending line 
indicates the time to maximize bone mineralization. Similar percentage bone ash values 
were found for the PC and NC1 where both treatments maximize at 44%. However, NC1 
maximized bone mineralization around 6 days while the PC took about 10 days. Low 
percentage bone ash was found for NC2 and NC3.  Both NC flocks registered a 
maximum response of 34.82 and 31.95%, respectively.  
 
 
Figure 4. Positive control percentage bone ash (Exp 1) Source: Sanderson Farms (Bryan, TX).  
[y=Max + Rate Constant*(Time to maximize –x)]. 
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Figure 5. Negative control percentage bone ash (Exp 1) Source: Sanderson Farms (Bryan, TX).            
[y=Max + Rate Constant*(Time to maximize –x)]. 
 
 
Figure 6. Negative control percentage bone ash (Exp 2) Source: Cobb hatchery (Timpson, TX).  
[y=Max + Rate Constant*(Time to maximize –x)] . 
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Figure 7. Negative control percentage bone ash (Exp 3) Source: Sanderson Farms (Bryan, TX).  
[y=Max + Rate Constant*(Time to maximize –x)2]. 
 
 
3.4 DISCUSSION 
           The results of the present study show the high variability within flocks in response 
to a vitamin D3-deficient diet when percentage bone ash is used to test the activity of 
vitamin D in bone mineralization of broiler chickens from different sources.  The biggest 
effect of this variability is observed in the maximum percentage bone ash registered for 
each experiment. Maximum percentage bone ash of 44, 34.8 and 31.95% were registered 
for Exp. 1, Exp. 2 and Exp. 3, respectively. This is in agreement with Thorp and 
Waddington (1997) who studied the incidence of different bone pathologies in broiler 
chickens obtained from different European countries and found that the prevalence and 
type of pathologies observed varied with the source of the broilers. The effect of 
maternal nutrition may influence the response of the progeny to multiple assays in 
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research studies, especially in bone quality measurements that are highly correlated with 
the endogenous reserves of vitamin D3 transferred in the egg yolk.  Any nutritional 
deficiency or inadequacy transferred from the breeder to the egg has a negative impact on 
the performance of the progeny (Moran, 2007). Murphy et al. (1936) studied the effect of 
vitamin D intake of the breeder hen on bone calcification of the growing chick, and 
stated that the antirachitic potency of the egg yolk is directly related with the hens 
vitamin D intake level; these authors further state that a direct correlation results between 
the antirachitic intake of the hen and the degree of bone calcification in the resultant 
chick during the first few weeks of age. Mattila et al. (1999) showed that 25-OH-D3 and 
cholecalciferol are transferred from the hen into the egg yolk and found a strong positive 
correlation between the hen’s vitamin D dietary level and the deposition in the egg yolk. 
Other studies with broiler breeder hens also show a direct relationship between the 
source and level of dietary vitamin D on the carryover effect to young chicks for 
adequate development. Breeders that were supplemented with high concentrations of 
cholecalciferol were able to maintain an active carryover effect, and their chick’s 
sustained growth and bone mineralization even 3 weeks after hatching when fed 5,500 
IU/kg D3. The supplementation with a dietary source of 25-OH-D3 enhanced the effect 
by improving the general performance of the progeny (Coto et al. 2010b).  This effect 
was also confirmed by Atencio et al. (2005b) who reported that chicks hatched from hens 
fed a dietary source of 25-OH-D3 improved body weight gain, gain:feed, feed intake, 
tibia ash and lowered mortality when compared to chicks hatched from hens fed only 
cholecalciferol.  Atencio et al. (2006) estimated that 2,000-4,000 IU/kg D3 was required 
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in breeder diets to maximize body ash of the progeny. Atencio et al. (2005a) studied the 
relationship of dietary cholecalciferol in the breeder hen and Ca levels in the progeny 
diet. He found that chicks hatched from eggs laid by hens fed high levels of vitamin D3 
(50 µg/kg or 2,000 IU/kg D3) and fed 0.9% Ca had the highest body weights and tibia ash 
and the lowest TD incidence versus those fed 0.63% Ca. Broiler breeder hens in the last 
phase of the laying cycle were able to transfer vitamin D more efficiently into the egg 
yolk than younger birds when fed high levels of cholecalciferol (50 µg/kg or 2,000 IU/kg 
D3) during the entire production cycle (Driver et al. 2006). Other nutritional factors not 
related with the diet itself may also influence in the response and incidence of bone 
disorders. Bar et al. (1986) studied different outbreaks of leg disorders in turkeys and 
stated that the incidence of field rickets was related more to a defect in vitamin D 
metabolism or in its expression rather than dietary factors. The incubation process and 
first day post-hatch management is critical since they can play a key role with respect to 
reaching the genetic potential of modern broiler strains (Kidd, 2009). In agreement with 
my results, Coates (1962) described several disadvantages responsible of the variability 
in the response to dietary treatments when chickens are used as laboratory subjects. He 
stated that the social hierarchy in groups of birds kept together results in variable food 
consumption and uneven growth rates within experimental groups; also their feeding 
habits make difficult to obtain accurate records of food intake that are used to evaluate 
performance.   
Bone ash values found for the first experiment in this study agree with those 
found by Lofton and Soares (1986) where percentage bone ash measured in 14-day-old 
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chicks was around 45% in birds fed a vitamin D3 deficient diet. Lofton and Soares (1986) 
data suggest that maternal deposition of vitamin D3 was enough to sustain growth and 
bone mineralization during the first 2 weeks of age. Contrary to Exp. 1, values registered 
in experiment 2 and 3 were below 45%  in agreement with Edwards et al. (1994) who 
found similar low percentage bone ash (27%) in chicks that were excluded from 
ultraviolet light exposure for 16 days. Overall a high variability in the maximum 
percentage bone ash response to the vitamin D3-deficient diet within flocks obtained 
from the same commercial hatchery and from different sources was observed; this 
variability may explain why in some cases, it can be difficult to find a consistent 
significant decrease in percentage bone ash as an indicator of the Vitamin D activity in 
young broilers. 
3.5 CONCLUSION 
In order to produce a vitamin D3-deficient status in young broiler chickens it is 
necessary to have strict control on the breeder’s diet. Regardless of the initial 
concentrations of vitamin D in newly hatched chickens obtained from different 
commercial hatcheries, the maternal reserves will deplete around day 10 of age but still a 
high variability in response to dietary vitamin D was observed when percentage bone ash 
was used to evaluate the vitamin D activity.  
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4. EVALUATION OF SERUM 25-OH-D3 DYNAMICS IN BROILER 
CHICKENS 
 
4.1 INTRODUCTION 
 By supplementing 25-OH-D3 (the major circulating form of vitamin D in the 
blood), the activity of vitamin D is increased relative to feeding cholecalciferol alone. 
Yarger et al. (1995) compared the bio-potency of 25-OH-D3 and cholecalciferol in 
broiler chickens. They found that serum 25-OH-D3 concentration increased more rapidly 
in birds that were supplemented with the vitamin D metabolite and performance was 
improved by increasing body weight and feed efficiency. Fritts and Waldroup (2003) 
compared the performance and bone ash content of growing broiler chickens fed 
different levels of 25-OH-D3 and cholecalciferol. Body weight and bone ash were 
significantly greater in birds fed the 25-OH-D3 when compared to cholecalciferol alone. 
The incidence of TD was also improved when 25-OH-D3 was supplemented to the diet.  
Ledwaba and Roberson (2003) studied the efficacy of 25OH-D3 in low Ca diets; the 
inclusion of 70 µg/kg 25-OH-D3 had a positive effect in preventing TD in marginal Ca 
diets. Chou et al. (2009) reported that the supplementation of 25-OH-D3 may improve 
the small intestine morphology and enhance the immune response of broiler chickens. In 
a previous study conducted by Huvepharma (Peachtree city, GA) and Tyson Foods Inc. 
(Springdale, AR), where 25-OH-D3 serum concentrations were calculated from blood 
samples taken from different commercial production cycles at different times of the year 
during broiler development, there was high variability and no consistent trend with 
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respect to vitamin D status. This variability opened a wide range of possibilities to 
explain this phenomenon: genetic variability, maternal deposition of vitamin D in the 
broiler chick egg yolk, individual feed intake, growth rate, and housing conditions could 
all be factors affecting the vitamin D status within each study. Tibia bone ash was also 
measured and percent of ash decreased after the second week for all sample sites, which 
could also be attributed to high variability in the vitamin D status. As previously 
mentioned, in the modern poultry industry leg health is an important component of 
broiler welfare and therefore in general broiler performance which is a critical economic 
issue for any poultry business.  
 Little information exists about the dynamics of serum concentrations of 25-OH-
D3 when supplemented in broiler feeds to prevent rickets and other bone problems. The 
purpose of this study was to better understand the dynamics of 25-OH-D3, identify if 
there was any “circadian-type” trend in the broiler´s response to dietary 25-OH-D3 over 
time, as well as identify important information about the effect of age in the metabolism 
of 25-OH-D3 and bone ash mineralization. 
4.2 MATERIALS AND METHODS 
4.2.1 Experimental design overview 
 Ross-308 newly hatched broiler chickens were purchased from a commercial 
hatchery and fed ad libitum a vitamin D3-deficient corn-soy broiler mashed starter diet 
for a 21-day rearing period. To create three treatments, the basal diet was subdivided and 
supplemented with 3,850 IU/kg cholecalciferol or 3,850 IU/kg cholecalciferol plus one 
of two sources of 25-OH-D3 at 0.5 kg/t (Hy-D™ and Bio-D™).  
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 On day 1 of age, 112 birds were divided in four groups of 28 birds and received 
the treatment diets ad libitum for a 24 h period. Four birds were taken from each group at 
times 0, 1, 2, 4, 8 12 and 24 h after presentation to the treatment diets to draw blood. Sera 
were collected from the blood samples and used to run a commercial ELISA Kit (25-OH-
Vitamin D Kit, Eagle Biosciences®). The left tibia of four birds sampled at 0-h of 
exposure to the treatment diets was removed to perform a bone ash determination as a 
percent of the fat-free, dried bone weight.  
 On days 4, 9, 14 and 19 of age, 88 birds were selected and divided into three 
groups and fasted overnight. The next day, after the fasting period, selected birds were 
offered the treatment diets ad libitum for 24 h.  Four birds were taken from each group of 
the three treatments at times 0, 1, 2, 4, 8 12, and 24 h after presentation to the treatment 
diets to draw blood. Sera were collected from the blood samples and split into two sub-
samples. One sub-sample was used to run a commercial ELISA (25-OH-Vitamin D Kit, 
Eagle Biosciences®) and the other one was sent to Heartland Assays (Ames, IA) for 
analysis of 25-OH-D3 and calcium concentration. The left tibia of four birds sampled at 
0-h of exposure to the treatment diets was removed to perform a bone ash determination 
as a percent of the fat-free, dried bone weight.  
 After the 24-h feeding period on days 2, 6, 11, 16 and 21, four remaining birds 
were individually marked with wing bands and placed back on the vitamin D3-deficient 
diet for the rest of the trial. On day 21, all marked birds were euthanized then the left 
tibia was removed to perform a bone ash determination as a percent of the fat-free, dried 
bone weight. 
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4.2.2 Housing and daily observations 
 Birds were caged in two Petersime battery brooders located in an environmentally 
controlled rearing room (# 1215) at the Texas A&M Poultry Research Farm. Minimal 
lighting in the room was provided on a constant 24-h basis. The complete absence of UV 
light in the rearing rooms has been verified previously (Fowler et al. 2014). Birds were 
observed daily with regard to general flock condition, temperature, lighting, water, feed, 
and unanticipated events for the rearing facility.  
4.2.3 Dietary treatments  
 A basal corn-soy vitamin D3-deficient broiler starter diet was formulated using a 
customized mineral/vitamin premix without vitamin D3 and utilizing corn oil as the fat 
source (Table 6). Treatment diets were supplemented with 3,850 IU/kg cholecalciferol, 
and with 0.5 kg/t Bio-D™ (Peachtree, GA) or Hy-D™ (Naperville, IL), which yields 
34.8 ppb and 68.9 ppb of 25-OH-D3 respectively. Feed samples were taken directly from 
a moving stream, and stored in a refrigerator at 11°C prior to being sent to Heartland 
Assays (Ames, IA) for vitamin D3 and 25-OH-D3 concentration analysis by Liquid 
Chromatography-Mass Spectrometry (LC/MS/MS).   
4.2.4 Feed and watering method 
 Vitamin D3-deficient diet was offered ad libitum for the 21-day rearing period 
except for the 24-h sample collection dates, when selected birds were offered the 
treatment diets after being fasted overnight. Water was offered ad libitum during the 
whole trial.  
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Table 6. Experimental basal vitamin D3 deficient diet
1
 
Ingredient % 
Corn 62.30 
Dehulled soybean meal 32.04 
DL-Methionine 0.23 
L-Lysine HCl 0.18 
Corn oil 1.97 
Limestone 1.06 
Monocalcium phosphate 1.19 
Salt 0.46 
Custom vitamin/mineral premix
2
 0.5* 
1
Calculated nutritional content was as follow: crude protein 22%, metabolizable energy 3050 
kcal/kg, calcium 0.75 %, available phosphorus 0.37 %, methionine 0.56 %, methionine+cystine 
0.92 %, lysine 1.31%, tryptophan 0.26 %, threonine 0.82% arginine 1.46%, crude fat 3.85% and 
crude fiber 2.16% 
2* 
Vitamin/mineral premix guaranteed analysis: Copper 2200ppm, Iodine 400 ppm, Iron 4,000 
ppm, Manganese 2.5%, Zinc 2.5%, Selenium  40 ppm, vitamin A 1,596,650 IU/kg and vitamin E 
7,964 IU/kg. Recommended inclusion level 5 kg/t to manufacture complete poultry feed. 
 
 
4.2.5 Sera samples 
 Blood was drawn at specific times (0, 1, 2, 4, 8, 12 and 24 h) after exposure to 
treatment diets. The blood was collected within Eppendorf® 1.5 ml tubes and centrifuged 
at 3000 x g for 10 min to separate the serum which then was split into two sub-samples. 
One sub-sample was used to run a commercial ELISA (25-OH-Vitamin D Kit Eagle 
Biosciences®) and the other was sent to Heartland Assays (Ames, IA) for analysis of 25-
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OH-D3 and calcium concentration via liquid chromatography mass-spectrometry 
(LC/MS/MS) and colorimetric methods, respectively. 
4.2.6 Bone ash determination 
         The left tibia was dissected from selected birds for bone ash determination to 
evaluate vitamin D3 activity. Muscle and cartilage were removed before being placed in 4 
L of petroleum ether for 48 h at room temperature. Following this, tibias were dried for 
24 h in a drying oven at 105°C. Finally tibias were ashed at 650°C for 23 h. Ash was 
evaluated as a percentage of the free-fat, dried bone weight. 
4.2.7 Statistical analysis  
         The serum 25-OH-D3 concentration data were subjected to repeated measures 
analysis using the GLM procedure of SPSS. Dietary treatments were used as fixed factor. 
Means were separated by Duncan´s multiple range test. Statistical significance was 
accepted at p≤0.05. Assay type data were analyzed using the pair correlation function of 
the same software. Broken-line regression was used to analyze the serum Ca 
concentration and percentage bone ash using the “Nutritional Response Model Program” 
Version 1.01 from Gene Pesti and Dmitry Vedenov, University of Georgia. Individual 
birds served as the experimental unit for percentage bone ash, serum 25-OH-D3 and Ca 
concentration data analysis.  
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4.3 RESULTS 
4.3.1 Initial serum 25-OH-D3 
 Table 7 shows the serum 25-OH-D3 concentration (ng/ml) of day-old chicks, where 
time 0 values represents the initial maternal D3 stores in egg yolk as birds were sampled 
prior to receiving any treatment feed.  
 
 
Table 7.  ANOVA day 1-ELISA serum 25-OH-D3 (ng/ml) 
 
Hour 
Treatment 
NC Vit. D Vit. D+ Bio-D Vit. D+ Hy-D 
0 40.36±8.11 
1 38.67±5.63 38.04±15.66 32.65±3.18 33.04±11.16 
2 41.63±7.82 31.76±10.45 29.47±7.06 34.24±5.09 
4 29.34±8.05 28.86±13.11 40.75±9.78 33.95±4.75 
8 37.53±1.27
b
 34.25±5.70
b
 36.12±5.54
b
 47.63±2.56
a
 
12 36.83±10.08 43.01±11.39 44.76±6.87 42.93±8.37 
24 33.28±7.01 51.89±7.96 52.39±25.71 29.67±7.83 
a,b Means within a row with no common superscript differ significantly (P<0.05). 
± Standard deviation. n= 4 birds per treatment per hour (n= 3 birds  for Vit. D 1 and 2 h, 
Vit.D+Bio-D for 8 and 24-h, NC  for 12-h).  Zero hour value represents the initial 25-OH-D3 (ng/ml) 
average of 96 total birds. 
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 Serum 25-OH-D3.from 1-4, 12 and 24 h were not different (p>0.05) when compared 
to the negative control. A difference was found at 8-h exposure to the treatments diets 
(p<0.05), where Vit. D+Hy-D treatment had higher values than NC, Vit. D and Vit. D+Bio-
D.  
4.3.2 Serum 25-OH-D3 assay type correlation  
 A correlation coefficient of 81% (r) was found between the assay type results (Table 
8), ELISA Kit vs LC/MS/MS performed by Heartland Assays (Ames, IA), an increasing 
positive relationship was found for both assays; however, only 65% of the total variation 
(r
2
) in the assay results can be explained by the linear relationship; therefore, a separate 
analysis of variance was done for each assay. Figures 10–17 and Tables 9-16 present the 
collected data for serum 25-OH-D3 concentration (ng/ml). 
 
 
Table 8. Assay type bivariate correlation 
Assay Type Coefficient of Correlation p value 
Heartland -  ELISA Kit 0.81 <0.001 
n= 335 for each assay 
 
 
 Serum 25-OH-D3 concentration Day 5 
 
 After 5 days of feeding the basal vitamin D3-deficient diet to the chickens, initial 
serum 25-OH-D3 concentration (0-h exposure to treatment diets) dropped from 40.4 of day-
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old chicks to 3.46 and 7.05 ng/ml for the ELISA Kit and LC/MS/MS, respectively, as yolk 
derived D3 started to deplete (Table 9). 
 ELISA Kit. - No significant (p>0.05) difference was found from 1-2 and 8-h 
exposure to treatment diets. At 4-h, Vit.D+Bio-D and Vit. D+ Hy-D registered higher 
values when compared to Vit. D alone (p<0.05). At 12 and 24 h Vit., D+Bio-D had 
intermediate values between Vit. D and Vit. D+Hy-D treatments (p<0.05) (Table 9).  
 
 LC/MS/MS.- There was no difference (p>0.05) between treatments on 1, 8 and 12 
h. At 2 and 4-h of exposure to treatment diets, a significant difference was found; Vit. D 
alone had lower concentration values than Vit. D+Bio-D and Vit.D+Hy-D (p<0.05). After 
24 h, Vit. D+Bio-D registered intermediate values between Vit. D and Vit.D + Hy-D 
(p<0.05) (Table 9). 
 The comparative linear increase of the serum 25-OH-D3 concentrations for both 
assays is presented in Figure 8. 
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Table 9.  Day-5 ANOVA (ELISA Kit versus LC/MS/MS) serum 25-OH-D3 (ng/ml) 
 
Hour Treatment 
 Vit. D Vit. D+ Bio-D Vit. D+ Hy-D 
 ELISA Kit 
0 3.46±1.06 
1 1.63±1.52 5.65±4.70 5.68±0.83 
2 3.58±2.08 7.29±2.99 5.81±2.88 
4 4.69±2.42
b
 9.64±1.79
a
 10.20±1.32
a
 
8 12.22±4.19 18.57±4.94 18.21±3.05 
12 8.93±2.85
b
 17.25±7.01
ab
 20.79±6.82
a
 
24 16.39±5.88
b 
25.62±16.10
ab 
38.65±4.86
a 
 LC/MS/MS 
0 7.05±1.53 
1 5.71±2.27 10.50±3.90 11.52±3.00 
2 6.60±1.92
b 
12.35±2.95
a 
12.23±2.20
a 
4 11.02±4.04
b 
16.77±1.44
a 
19.47±1.31
a 
8 17.07±3.05 26.18±8.82 26.37±2.78 
12 18.39±6.66 28.04±6.77 30.87±9.01 
24 27.95±3.72
b 
39.96±16.37
ab 
52.31±5.90
a 
a,b Means within a row with no common superscript differ significantly (P<0.05). 
± Standard deviation. n= 4 birds per treatment per hour. Zero hour value represents the initial 25-
OH-D3 (ng/ml) average of 76 total birds. 
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ELISA KIT 
 
LC/MS/MS 
 
Figure 8.Comparative linear increase Day-5 ELISA vs LC/MS/MS serum 25-OH-D3 values (ng/ml) 
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  Serum 25-OH-D3 concentration Day 10 
 
 Initial serum 25-OH-D3 concentration after 10 days on the vitamin D3-deficient diet 
for ELISA Kit (4.26 ng/ml)  and LC/MS/MS (6.28 ng/ml) was very similar to the 5-day 
value, a decrease was observed when compared to the day-old chick initial value 40.36 
ng/ml that represents the initial maternal D3 stores (Table 10). The linear increase trend for 
both assays is presented in Figure 9. 
 ELISA Kit.-  At 8 h Vit. D+Bio-D had intermediate concentration when compared 
to  Vit. D and Vit. D+Hy-D and at 24 h Vit.D+Bio-D and Hy-D had a significant increase in 
serum 25-OH-D3 when compared to the Vit. D treatment.  (p<0.05) (Table 10). 
 LC/MS/MS.-   At 2 and 24 h, Vit. D+Bio-D and Hy-D had higher concentration 
values than Vit. D alone (p<0.05). After 8 and 12-h exposure to dietary treatments 
intermediate values for Vit.D+Bio-D were observed compared to Vit.D and Vit.D+Hy-D.  
(Table 10).  
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Table 10.  Day-10 ANOVA (ELISA Kit versus LC/MS/MS) serum 25-OH-D3 (ng/ml) 
 
Hour Treatment 
 Vit. D Vit. D+ Bio-D Vit. D+ Hy-D 
 ELISA Kit 
0 4.26±3.04 
1 4.47±2.25 4.03±3.45 1.59±1.53 
2 0.64±1.28 3.43±1.97 4.90±3.74 
4 3.73±2.47 4.59±5.69 5.29±3.83 
8 8.49±2.33
b 
11.99±4.47
ab 
19.72±5.73
a 
12 11.96±3.02 16.17±6.08 19.04±2.31 
24 17.50±3.32
b 
34.22±5.82
a 
36.23±10.52
a 
 LC/MS/MS 
0 6.28±4.14 
1 10.02±3.92 9.07±5.07 6.58±2.47 
2 5.38±4.11
b 
14.15±2.21
a 
12.88±4.84
a 
4 9.95±1.40 19.02±6.52 16.78±5.94 
8 19.10±3.88
b 
27.64±5.80
ab 
35.19±6.89
a 
12 25.59±2.86
b 
33.75±9.65
ab 
40.22±5.27
a 
24 33.36±6.18
b 
60.08±8.89
a 
56.46±15.28
a 
a,b Means within a row with no common superscript differ significantly (P<0.05). 
± Standard deviation. n= 4 birds per treatment per hour. Zero hour value represents the initial 25-
OH-D3 (ng/ml) average of 76 total birds. 
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ELISA Kit 
 
LC/MS/MS 
 
Figure 9. Comparative linear increase Day-10 ELISA vs LC/MS/MS serum 25-OH-D3 values 
(ng/ml) 
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  Serum 25-OH-D3 concentration Day 15 
 
 ELISA Kit. - At 2 h, Vit.D+Bio-D treatment registered higher concentration values 
than Vit.D and Vit.D+Hy-D. At 4-h Vit. D+Hy-D registered the highest values and after 8 h 
all treatments were significantly different. With Vit. D showing the lowest serum 25-OH-D3 
values. Intermediate values of Vit.D+Bio-D were found at 12 h and at 24 h. Both 
Vit.D+Bio-D and Hy-D had a significant increment in serum 25-OH-D3 values compared to 
Vit.D treatment (p<0.05) (Table 11). 
 LC/MS/MS.- From 1 to 24 h, Vit. D+ Bio-D and Vit-D+Hy-D resulted in 
significant increment in 25-OH-D3 concentration values when compared to Vit. D alone. 
Only at 4 h did Vit. D+Bio-D  registered lower values than Vit.D+Hy-D (p<0.05) (Table 
11). 
 Figure 10 shows the linear trend of the serum 25-OH-D3 values for both assays over 
time, maximum values were reached after 24 h exposure to treatment diets.  
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Table 11.  Day-15 ANOVA (ELISA Kit versus LC/MS/MS) serum 25-OH-D3 (ng/ml) 
 
Hour Treatment 
 Vit. D Vit. D+ Bio-D Vit. D+ Hy-D 
 ELISA Kit 
0 4.61±4.06 
1* 2.94±2.31 4.86±0.30 6.47±2.56 
2 2.74±1.25
b 
11.10±0.76
a 
6.76±4.44
b 
4 6.40±2.68
b 
8.85±1.14
b 
15.67±3.91
a 
8 11.30±0.86
c 
17.90±4.85
b 
23.58±1.55
a 
12 15.08±5.11
b 
25.03±4.48
ab 
29.76±10.37
a 
24 
24.97±4.24
b 
37.93±5.87
a 
39.62±8.08
a 
 LC/MS/MS 
0 7.71±3.15 
1* 7.29±1.86
b 
11.06±1.45
a 
13.97±2.76
a 
2 8.72±0.93
b 
18.00±1.45
a 
17.47±3.98
a 
4 13.15±2.53
c 
20.56±1.86
b 
26.84±3.64
a 
8 19.07±2.73
b 
33.54±6.11
a 
33.37±4.12
a 
12 22.95±5.47
b 
34.69±5.36
a 
39.89±8.71
a 
24 29.29±4.77
b 
49.79±6.73
a 
52.68±7.68
a 
a,b,c  Means within a row with no common superscript differ significantly (P<0.05). 
± Standard deviation. n= 4 birds per treatment per hour. Zero hour value represents the initial 25-
OH-D3 (ng/ml) average of 76 total birds. * Vit.D+Bio-D  (n= 3 brids).   
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ELISA Kit  
 
LC/MS/MS 
 
Figure 10. Comparative linear increase Day-15 ELISA vs LC/MS/MS serum 25-OH-D3 values 
(ng/ml) 
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  Serum 25-OH-D3 concentration Day 20 
 
 ELISA Kit. - Significant differences were found after 2-h exposure to treatments, 
with Vit. D+Hy-D having higher values than Vit.D and Vit. D+Bio-D.  At 4 h, Vit. D had a 
significant lower values than the other two treatments. After 12 h, Vit. D+Bio-D had 
intermediate values between Vit. D and Vit.D+Hy-D (p<0.05) (Table 12). 
 LC/MS/MS.-  At 1 and 2 h, Vit.D had an intermediate effect when compared to 
Vit.D and Vit.D+Hy-D. From 4 to 24 h Vit. D+Bio-D and Vit.D+Hy-D had significantly 
higher values than Vit.D. Only at 12 h was Vit. D+Bio-D significantly (p<0.05) lower than 
Vit.D+Hy-D (Table 12). 
  No “circadian” type trend was observed after the 24-h exposure to the treatment 
diets for any of the assays (Figure 11).  
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Table 12.  Day-20 ANOVA (ELISA Kit versus LC/MS/MS) serum 25-OH-D3 (ng/ml) 
 
Hour Treatment 
 Vit. D Vit. D+ Bio-D Vit. D+ Hy-D 
 ELISA Kit 
0 8.47±2.32 
1 6.84±3.52 7.74±2.10 12.91±3.91 
2 11.08±1.44
b 
11.24±1.68
b 
15.93±3.14
a 
4 10.73±0.39
b 
19.93±4.17
a 
18.82±6.50
a 
8 17.51±2.83 24.20±7.32 29.36±6.36 
12 19.67±4.72
b 
31.31±5.43
ab 
38.15±11.52
a 
24 37.40±7.85 48.65±8.83 54.27±13.79 
 LC/MS/MS 
0 8.00±2.62 
1 8.25±0.93
b 
12.47±4.89
ab 
15.40±1.78
a 
2 12.15±1.46
b 
14.63±1.90
ab 
16.53±1.99
a 
4 12.20±1.56
b 
22.74±2.81
a 
24.30±4.74
a 
8 17.75±1.97
b 
26.81±5.84
a 
30.05±2.24
a 
12 21.74±2.13
c 
30.47±3.32
b 
38.12±6.38
a 
24 30.38±4.38
b 
47.57±7.94
a 
47.92±9.20
a 
a,b Means within a row with no common superscript differ significantly (P<0.05). 
± Standard deviation. n= 4 birds per treatment per hour. Zero hour value represents the initial 25-
OH-D3 (ng/ml) average of 76 total birds. 
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ELISA Kit 
 
LC/MS/MS  
 
Figure 11. Comparative linear increase Day-20 ELISA vs LC/MS/MS serum 25-OH-D3 values 
(ng/ml) 
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4.3.3 Serum Ca concentration 
 
 Calcium concentration was analyzed by Heartland Assays via colorimetric assay. 
Figures 12-23 show the Ca values at different samples times for the 24-h period exposure to 
the treatment diets. The breaking point of the ascending line indicates the approximate 
necessary time to reach stable levels in the blood.  
 Serum Ca concentration Day-5 
 
 
 
Figure 12. Vit. D treatment serum Ca concentration day-5 (mg/dL). 
 [y=Max +Rate constant*(Time to maximize-x)]. 
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Figure 13. Vit. D + Bio-D treatment serum Ca concentration day-5(mg/dL). 
 [y=Max +Rate constant*(Time to maximize-x)]. 
 
 
 
Figure 14. Vit. D + Hy-D treatment serum Ca concentration day-5(mg/dL). 
[y=Max +Rate constant*(Time to maximize-x)]. 
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 Serum Ca concentration Day-10 
 
 
 
Figure 15. Vit. D treatment serum Ca concentration day-10 (mg/dL). 
[y=Max +Rate constant*(Time to maximize-x)]. 
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Figure 16. Vit. D + Bio-D treatment serum Ca concentration day-10 (mg/dL). 
[y=Max +Rate constant*(Time to maximize-x)]. 
 
 
 
Figure 17. Vit. D + Hy-D treatment serum Ca concentration day-10 (mg/dL). 
[y=Max +Rate constant*(Time to maximize-x)]. 
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 Serum Ca concentration Day-15 
 
 
 
Figure 18. Vit. D treatment serum Ca concentration day-15 (mg/dL). 
[y=Max +Rate constant*(Time to maximize-x)]. 
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Figure 19. Vit. D + Bio-D treatment serum Ca concentration day-15(mg/dL). 
[y=Max +Rate constant*(Time to maximize-x)]. 
 
 
 
Figure 20. Vit. D + Hy-D treatment serum Ca concentration day-15 (mg/dL). 
[ y=Max +Rate constant*(Time to maximize-x)]. 
 
 
6
7
8
9
10
11
12
13
14
15
16
0 2 4 6 8 10 12 14 16 18 20 22 24
C
a
 m
g
/d
L
 
h 
6
7
8
9
10
11
12
13
14
15
16
0 2 4 6 8 10 12 14 16 18 20 22 24
C
a
  
m
g
/d
L
 
h 
 Max. Rate Constant 
Value 11.35 -0.82 
SE 0.256 89431893 
p-value <0.001 1 
R
2
 2.96% 
 
0.69 
0.45 
 Max. Rate Constant 
Value 11.35 -0.82 
SE 0.256 89431893 
p-value <0.001 1 
R
2
 2.96% 
 
 57 
 
 
 Serum Ca concentration Day-20 
 
 
 
Figure 21. Vit. D treatment serum Ca concentration day-20 (mg/dL). 
[y=Max +Rate constant*(Time to maximize-x)]. 
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Figure 22. Vit. D + Bio-D treatment serum Ca concentration day-20 (mg/dL). 
 [y=Max +Rate constant*(Time to maximize-x)]. 
 
 
 
Figure 23. Vit. D + Hy-D treatment serum Ca concentration day-20 (mg/dL). 
 [y=Max +Rate constant*(Time to maximize-x)]. 
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 Figures 12-23 show the effect of the 25-OH-D3 on the blood Ca levels. During the 
first 10 days the initial Ca concentration was around 9 mg/dL. For days 15 and 20 of age, 
Ca levels were already around 10 mg/dL which is the normal concentration in the blood and 
a lower response was observed. No consistent response was observed in Ca concentration 
among treatments.  
 The analysis of variance among treatments per sampled hour for the serum Ca 
values is presented in Tables 13-16.  
 At day-5 Vit.D+Bio-D had significantly higher Ca levels compared to Vit.D and 
Vit.D+Hy-D after 8-h exposure to treatment diets (Table 13). 
 
Table 13. ANOVA day-5 serum Ca mg/dL 
 
Hour 
Product 
Vit. D Vit. D+ Bio-D Vit. D+ Hy-D 
0 8.20±0.59 
1 10.25±0.63 9.61±2.07 10.06±1.80 
2 10.23±0.96 9.67±1.96 10.76±1.13 
4 11.39±0.51 11.85±1.03 11.31±0.38 
8 9.82±1.53
b 
11.98±0.64
a 
10.83±0.61
ab 
12 11.71±1.26 12.88±1.95 12.57±0.71 
24 12.70±0.70 12.69±1.29 11.85±1.17 
a,b,  Means within a row with no common superscript differ significantly (P<0.05). 
± Standard deviation. n= 4 birds per treatment per hour . Zero hour value represents the initial Ca 
(mg/dL) average of 76 total birds. 
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Table 14. ANOVA day-10 serum Ca mg/dL 
 
Hour 
Product 
Vit. D Vit. D+ Bio-D Vit. D+ Hy-D 
0 9.23±1.35 
1 9.38±1.49
ab 
10.96±1.52
a 
7.99±1.40
b 
2 9.86±1.30 10.32±1.61 12.09±2.04 
4 11.77±0.98 11.06±0.89 12.39±2.21 
8 10.70±1.14
b 
10.71±1.61
b 
13.55±0.81
a 
12 12.98±0.59
a 
11.07±1.55
b 
13.46±1.14
a 
24 13.78±0.68 12.55±1.47 14.57±1.67 
a,b, Means within a row with no common superscript differ significantly (P<0.05). 
± Standard deviation. n= 4 birds per treatment per hour. Zero hour values represent the initial Ca 
(mg/dL) average of 76 total birds. 
 
 
 
 On day 10 of age a significant increment was observed for Vit.D+Bio-D  when 
compared the other two treatments at 1-h exposure. At 8-h Vit.D+Hy-D was significantly 
higher than Vit.D and Vit.D+Bio-D. Finally at 12-h Vit.D+Bio-D had the lowest values of 
all (Table 14). 
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Table 15. ANOVA day-15 serum Ca mg/dL 
 
Hour 
Product 
Vit. D Vit. D+ Bio-D Vit. D+ Hy-D 
0 10.78±0.92 
 1* 12.15±0.83
a 
12.14±1.22
a 
9.72±0.71
b 
2 11.34±0.12 10.39±2.02 10.41±0.60 
4 13.47±1.45
a 
10.60±0.61
b 
11.94±0.80
ab 
8 12.52±1.47 11.04±0.43 11.04±0.66 
12 12.65±1.07 11.49±0.33 11.44±0.64 
24 14.22±0.72
a 
12.64±0.62
b 
12.33±0.32
b 
a,b,  Means within a row with no common superscript differ significantly (P<0.05). 
± Standard deviation. n= 4 birds per treatment per hour * Vit.D+Bio-D  (n= 3 brids). Zero hour 
values represent the initial Ca (mg/dL) average of 76 total birds. 
 
 
 On day 15 Vit.D and Vit.D+Bio-D were significantly different from Vit.D+Hy-D 
during the first hour. At 4-h Vit.D+Hy-D had intermediate values between Vit.D and 
Vit.D+Bio-D. After 24-h Vit.D had significantly higher levels of Ca when compared to the 
other two treatments (Table 15). 
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Table 16. ANOVA day-20 serum Ca mg/dL 
 
Hour 
Product 
Vit. D Vit. D+ Bio-D Vit. D+ Hy-D 
0 10.35±1.29 
1 12.04±0.61 12.11±0.74 11.83±1.71 
2 11.89±0.97 11.41±0.55 12.24±0.71 
4 12.89±0.35
a 
12.81±0.57
a 
11.94±0.52
b 
8 12.28±0.40 12.49±0.49 12.91±0.78 
12 12.04±0.46 12.61±0.39 12.19±0.51 
24 13.32±0.58 12.98±1.14 13.81±0.45 
a,b, Means within a row with no common superscript differ significantly (P<0.05). 
± Standard deviation. n= 4 birds per treatment per hour. Zero hour values represent the initial Ca 
(mg/dL) average of 76 total birds. 
 
 
  At 20 days of age only one difference was found. At 4-h, Vit.D and Vit.D+Bio-D had a 
higher increment in Ca concentration than Vit.D+Hy-D. (p<0.05) (Table 16). 
 A correlation coefficient of 58% (r) between serum Ca and 25-OH-D3 was found 
(Table 17). The weak relationship may be due to the stabilization of Ca levels that occurred 
during the first hours of exposure to the treatment diets, while the concentration of 25-OH-
D3 increased during the 24-h of exposure and stable levels were not reached during this 
time. 
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Table 17.  Calcium vs 25-OH-D3 bivariate correlation 
Variables Coefficient of Correlation p value 
Calcium – 25-OH-D3 0.58 <0.001 
n= 335 birds per variable 
 
 
4.3.4 Percentage tibia bone ash  
 
 Figure 24 show the percentage bone ash of the birds sampled at 0-h exposure to the 
treatment diets, meaning that, they were always fed the deficient vitamin D3 diet and served 
as a negative control. Bone ash data showed that chickens were able to support bone 
mineralization and growth with the maternal vitamin D3 found in the egg yolk (40.36 ng/ml) 
up to 10.60 days when % tibia ash was maximized.  
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Figure 24. Percentage bone ash of chickens under vitamin D3 deficient diet (NC).  
The tibia was dissected on days 1, 5, 10, 15 and 20 days of age at 0 hours exposure to treatment 
diets. Four birds per day.  [y=Max +Rate constant*(Time to maximize-x)]. 
 
 
  Table 18 show the percentage tibia ash of chickens at 1, 5, 10, 15 or 20-days of age 
that were fed the treatment diets for 24-h and compared to the NC. The birds were placed 
back on the NC diet after the 24-h feeding period.  All samples were taken at day-21 of age. 
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Table 18. Percentage bone ash evaluation one way ANOVA of chickens fed treatment 
diets one time for 24 h 
 
% Bone Ash NC Vit. D Vit. D +Bio-D Vit. D +Hy-D 
 Day-old chicks fed one time treatment diets (NC) 
 46.79±1.80 47.10±3.18 47.23±2.43 47.26±0.62 
 Fed treatment diets one time at Day-5 
 46.79±1.80 47.49±1.67 47.01±0.58 48.49±2.17 
 Fed treatment diets one time at Day-10  
 46.79±1.80 46.04±1.96 49.86±2.15 47.26±2.80 
 Fed treatment diets one time at Day-15  
 46.79±1.80 48.87±0.98 46.83±2.02 49.01±1.54 
 Fed treatment diets one time at Day-20 
 46.79±1.8
b
 49.10±1.2
a
 46.14± 0.7
b
 49.37±1.3
a
 
a,b Means within a row with no common superscript differ significantly (P<0.05). 
± Standard deviation. n= 4 birds per treatment. 
 
 
 No significant (p>0.05) difference was found in the percentage bone ash among 
treatments when compared to NC on days 1-15. On day 20, percentage bone ash values for 
Vit. D and Vit.D +Hy-D were significantly (p<0.05) higher than Bio-D and NC treatments 
(Table 18). 
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4.3.5 Feed analysis (Heartland assays analysis of 25-OH-D3, 25-OH-D2 and vitamin D3 
concentration via LC/MS/MS) 
 
 Samples were taken directly from a moving stream, and stored in a refrigerator at 
11°C prior to being send to analysis. Tables 18-21 show the concentrations of vitamin D3, 
25-OH-D3 and 25-OH-D2 metabolites in the feed samples.  
 
Table 19. Basal vitamin D3-deficient diet (NC) 25-OH-D3, 25-OH-D2 and vitamin D3 
concentration (ppb) 
 
Test  Name Result Unit 
25-OH-D3 (LC/MS/MS) 25-OH-D2 < 0.5 ppb 
25-OH-D3 (LC/MS/MS) 25-0H-D3 3.6 ppb 
Vitamin D3 (LC/MS/MS) Vitamin D3 18.2 ppb 
 
 
Table 20. Vitamin D3 diet ( Vit. D) 25-OH-D3, 25-OH-D2 and vitamin D3 concentration 
(ppb) 
 
Test Name Result Unit 
25-OH-D3 (LC/MS/MS) 25-OH-D2 < 0.5 ppb 
25-OH-D3 (LC/MS/MS) 25-OH-D3 23.8 ppb 
Vitamin D3 (LC/MS/MS) Vitamin D3 335.1 ppb 
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Table 21. Vitamin D3 + Bio-D diet (Vit.D+Bio-D) 25-OH-D3, 25-OH-D2 and vitamin D3 
concentration (ppb) 
 
Test Name Result Unit 
25-OH-D3 (LC/MS/MS) 25-OH-D2 < 0.5 ppb 
25-OH-D3 (LC/MS/MS) 25-OH-D3 89.7 ppb 
Vitamin D3 (LC/MS/MS) Vitamin D3 398.9 ppb 
 
 
Table 22. Vitamin D3+ Hy-D diet (Vit.D+Hy-D) 25-OH-D3, 25-OH-D2 and vitamin D3 
concentration (ppb) 
 
Test  Name Result Unit 
25-OH-D3 (LC/MS/MS) 25-OH-D2 < 0.5 ppb 
25-OH-D3 (LC/MS/MS) 25-OH-D3 117.5 ppb 
Vitamin D3 (LC/MS/MS) Vitamin D3 304.8 ppb 
 
 
4.4 DISCUSSION 
A good understanding of the 25-OH-D3 dynamics in the broiler chicken is 
fundamental to assess the metabolism and status of vitamin D (Bouillon, 1976), which 
ultimately will allow us to have a precise knowledge of its effects when different dietary 
levels and sources of vitamin D are studied. In this study, no “circadian type” trend was 
found between experimental treatments but rather a linear positive increase throughout 
time was observed. A significant difference between feeding cholecalciferol alone or 
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cholecalciferol plus one of the two sources of 25-OH-D3 was also shown. In agreement 
with the results obtained in this study, Clark and Potts (1977) found that there is a linear 
relationship between the intake of vitamin D3 and the serum levels of 25-OH-D3.  Also, 
Yarger et al. (1995) compared the effect of feeding cholecalciferol alone or with 25-OH-
D3 at different concentration levels and found a significant dose response relationship 
with serum 25-OH-D3 concentrations increasing more rapidly in birds fed 25-OH-D3 
than in birds fed cholecalciferol alone.   
Our results showed that the reduction in the serum 25-OH-D3, when compared to 
the initial concentration sampled in the day-old chickens at 0-h exposure to treatment 
diets (40.36 ng/ml), is a good indicative of the depletion status of the maternal vitamin D 
stores in the egg yolk.    
A significant difference was found in percentage bone ash in chickens fed the 
treatment diets for 24 h at day 20 of the trial. Feeding cholecalciferol plus 25-OH-D3 as 
Hy-D™ resulted in an improvement on bone ash of 5% when compared to the negative 
control, while feeding cholecalciferol plus Bio-D™ was not able to significantly improve 
the percentage bone ash. This is contrary to the previous results, form research done in 
our laboratory which support the hypothesis that supplementation of 25-OH-D3 as Bio-
D™ outperforms equivalent amounts of cholecalciferol (62.5, 125, 250, 500, and 1000 
IU/kg) and improves percentage bone ash values when compared to those of vitamin D3-
deficient chickens (Fowler et al., 2014). Boris et al. (1982) supported the positive effect 
of supplemental 25-OH-D3 in broiler diets.  He compared the activity of cholecalciferol 
and 25-OH-D3 in bone ash and found the vitamin D3 metabolite promote 50-100% 
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increase in percentage bone ash content.  Positive effects of feeding supplemental 25-
OH-D3 in performance and mineralization of the bones have been suggested in recent 
studies. Fritts and Waldroup (2003) compared performance and bone ash content of 
growing broiler chickens fed different levels of 25-OH-D3 and cholecalciferol. Body 
weight and bone ash were significantly greater in birds fed 25-OH-D3 when compared to 
cholecalciferol alone. Bar et al. (2003) stated that 5-10 µg/kg 25-OH-D3 were sufficient 
to ensure normal body weight and bone ash in chickens under continuous lighting. The 
inclusion of 40-70 µg/kg 25-OH-D3 improved phytate P retention and decreased the 
incidence of TD. A total of 70 µg/kg 25-OH-D3 was needed to decrease TD in diets with 
marginal concentration of Ca (Ledwaba and Roberson, 2003). Chou et al. (2009) studied 
the effect of supplemental 25-OH-D3 in broiler diets and found an improvement in the 
small intestine morphology, villus length of the duodenum and jejunum were longer. 
Also, a higher ratio of villus length to crypt depth was observed in duodenum and 
jejunum and a better humoral immunity response to Salmonella challenge was also 
observed. In broiler breeder hens the supplementation of 25-OH-D3 had positive effects 
when compared to cholecalciferol with respect to increasing body ash of the progeny to 
1.08 and 1.02 times higher at 3.125 µg/kg and 12.5 µg/kg 25-OH-D3 respectively. 
Hatchability was also increased 1.67 times at 3.125 µg/kg 25-OH-D3 (Atencio et al., 
2005b). Contrary to the previous studies, Cantor and Bacon (1978) fed between 1.25 and 
5 µg/kg of vitamin D3 or 25-OH-D3 to cage-reared, male broiler chicks and observed no 
differences in frequency of broken bones when comparing the two vitamin D3 forms; 
although no negative effects of 25-OH-D3 supplementation were observed either.   
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In the present study, the supplementation of 25-OH-D3 resulted in an increase in 
plasma Ca during the first few hours after the chickens were exposed to the treatments 
diets. This effect was more evident during the first weeks of age until Ca levels stabilized 
at around 10 mg/dL, but no consistent trend was found in Ca levels throughout time in 
response to the supplemental sources of 25-OH-D3. This is in agreement with Knowles et 
al. (1935) who described the variation of Ca levels in laying hens using blood samples 
drawn at different time points. Experimental hens responded to subcutaneous injections 
of parathormone by increasing the blood Ca concentration. The response was described 
as rapid and sudden after the subcutaneous injection. This rapid increase of Ca levels in 
the blood is also supported by Koch et al. (1984) who measured the responsiveness of 
parathyroid function in chickens with induced hypoglycemia, birds responded within 
minutes to an ethyleneglycol-bis-(B-aminoethylether)-N,N'-tetraacetic acid (EGTA) 
challenge used to induce depression of the blood ionic Ca concentration. McNutt and 
Haussler (1973) evaluated the nutritional effect of 25-OH-D3 and l,25(OH)2 D3 in 
preventing rickets, weight gain and maintenance of plasma calcium in white Leghorn 
chickens. He found that l,25(OH)2 D3 and 25-OH-D3 were 1.5 to 2.2 times as effective as 
cholecalciferol with respect to stimulation of weight gain and maintenance of plasma 
calcium levels.  
In the present study, dietary Ca and available P were lowered from 1.0 and 0.45 
% (NRC, 1994) to 0.75 and 0.37 %, respectively, with the purpose of increasing the 
pressure of the treatment diets to stabilize plasma Ca levels, and identify any effect in 
preventing vitamin D-deficiency signs in the broiler chickens. However, the three 
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treatment diets were able to increase the plasma Ca within the first hours of exposure to 
the treatment diets at a similar rate and no deficiency signs were observed either.  
Contrary to our results, The importance of adequate dietary calcium was studied by 
Williams et al. (2000) where chickens being fed a low-Ca diet had higher incidence of 
tibial dyschondroplasia and hypocalcaemia rickets, suggesting that diets for rapid growth 
modern strains may be low in available P but not in Ca. 
4.5 CONCLUSION 
No “circadian” trend line was found in serum 25-OH-D3 concentrations over time 
but a positive linear increase was observed, supporting the theory that 25-OH-D3 is in 
fact a partially active storage form of vitamin D3 and is a good marker to assess the status 
of vitamin D in the broiler chicken. A significant difference was found between 25-OH-
D3 supplemental sources when compared to feeding cholecalciferol as the only source of 
vitamin D3.  In general feeding Bio-D™ or Hy-D™ as a supplemental source of 25-OH-D3 
had a significant positive effect in increasing the serum levels the 25-OH-D3 and therefore 
increase the availability of this metabolite for further biological functions, especially after 
10 days of age. No consistent trend was found in the response of blood Ca concentrations to 
supplemental 25-OH-D3.  
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5. EVALUATION OF INCREASING DOSES OF VITAMIN D3 ON THE 
REQUIREMENT, GROWTH PERFORMANCE AND BONE 
MINERALIZATION OF GROWING CHICKENS 
 
5.1 INTRODUCTION 
 Intensive genetic selection in modern poultry strains has led to increase 
productivity, thanks to the improvement of growth rate and feed efficiency. Along with 
this intensive process, changes in the nutrient requirements for growing chickens are 
probable as suggested by different authors whose research indicates that higher 
requirements than those established in the NRC (1994) are needed to maximize 
performance.  
 Vitamin D3 is known to have an important function in the regulation of Ca and P 
levels in plasma to support good mineralization of bones, which is very important when 
raising broiler chickens under intensive industry conditions where mortality due to bone 
problems represents a major economic issue. In order for vitamin D3 to have biological 
function, it must undergo a hydroxylation in the liver to form 25-hydroxycholecalciferol 
(25-OH-D3) which is the major circulating form of Vitamin D3 in the blood, and then a 
second hydroxylation takes place in the kidneys to form 1,25-dihydroxycholecalciferol 
(l,25-(OH)2-D3) the most active metabolite in bone. The NRC (1994) vitamin D3 
requirement for growing Leghorn and broiler chickens is 200 IU/kg,  some authors  still  
consider this requirement as adequate to promote bone mineralization, growth and 
immune functions in modern strains of chickens (Baker et al., 1998, Fowler at al., 2014), 
 73 
 
while others suggest that higher amounts of vitamin D3 (1,000-3,500 IU/kg) are needed 
to support the growth rate of modern strains (Kasim and Edwards, 2000, Ledwaba and 
Roberson, 2003, Whitehead et al., 2004, Khan et al., 2010). The quantitative requirement 
of growing chickens for vitamin D is usually based on measurements of bone quality, 
such as bone ash content or incidence of rickets, which have been found to be more 
sensitive indicators than growth rate (Edwards et al., 1994). The vitamin D requirement 
may change depending on many factors such as dietary Ca and P, housing conditions, or 
metabolic disorders like impaired liver activity due to stress conditions such as bird 
density, heat stress, and diseases; mycotoxicosis, enteritis, malabsorption syndrome, and 
certain immune disorders (Yarger et al., 1995).  
 The use of the GE Dual X-ray absorptiometry (DEXA) scan offers a good 
alternative assay to analyze bone quality and body composition. The DXA´s ability to 
assess bone in a precise and fast way using a low radiation dose expands the research 
boundaries to evaluate the activity of nutrients such as vitamin D3 in bone mineralization 
and health.   
 Recent research done in our laboratory supports the lower requirement suggested 
by the NRC (1994) and Baker et al. (1998).  The objective of this study was to re-
evaluate the vitamin D3 requirement using a precise and controlled protocol where 
leghorn chickens received a daily oral gavage of pure cholecalciferol and bone 
mineralization and performance response to the treatments were evaluated using a 
broken-line regression analysis.  
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5.2 MATERIALS AND METHODS 
5.2.1 Experimental design overview 
 A pen containing 50 hens and 7 roosters (64 week old) Hy-Line breeders was fed 
a vitamin D3-deficient breeder diet for 1 month for maternal vitamin D3 depletion 
purposes; eggs collected during this period were discarded. After the 4-week depletion 
period, hatching eggs were collected twice a day for 7 days and stored in a cool room at 
18.3° C. These eggs were placed in a GQF® automatic incubator at 37.5 °C and 50-60 % 
humidity for 18 days and then transferred to a GQF® hatcher at 36.9 °C and 60-70% 
humidity.  A total of 96 newborn Hy-line chickens (6 birds per pen, 2 pen reps per 
treatment) were placed in one Petersime battery brooder unit located in an 
environmentally controlled rearing room (# 1215) at the Texas A&M Poultry Research 
Farm, and fed ad libitum a corn-soy vitamin D3-deficient broiler starter diet for a 21-day 
rearing period.  Birds were kept away from any source of UV light that may influence 
calcification from endogenous synthesis of cholecalciferol. 
 An external liquid concentrated source of Vitamin D3 (Pure Life® Labs) 
containing 50,000 IU/ml was diluted to achieve concentrations yielding 0, 40, 80, 160, 
200, 400, 800, 1,600 IU D3/kg. Chickens received a daily gavage during the 21-day 
rearing period. Weekly feed consumption and daily body weight per pen were recorded 
to evaluate performance. Birds were monitored twice a day with regard to general flock 
condition, mortality, temperature, lighting, water, feed, and unanticipated events for the 
rearing period. At day 21 of age the left tibia was removed to perform a bone ash 
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determination as a percent of the fat-free, dried bone weight to evaluate vitamin D3 
activity. 
5.2.2 Housing and daily observations 
 Breeders: A total of 50 hens and 7 roosters (64 week old) Hy-Line breeders were 
placed in a pen located at building #1210 at the Texas A&M Poultry Research Farm. 
During the depletion and collecting periods daily observations were done with regard 
general flock condition, mortality, water etc. 
 Chickens: Birds were caged in one Petersime battery brooder located in an 
environmentally controlled rearing room (# 1215) at the Texas A&M Poultry Research 
Farm. Minimal lighting in the room was provided on a constant 24-h basis. The complete 
absence of UV light in the rearing rooms has been verified previously (Fowler et al. 
2014) Birds were observed twice a day with regard to general flock condition, 
temperature, lighting, water, feed, and unanticipated events for the rearing facility. 
Weekly feed consumption and daily body weight per pen were recorded to evaluate 
performance. 
5.2.3 Egg management and incubation 
 Eggs were collected and discarded during the whole depletion period (4 weeks). 
After the depletion period eggs were collected for 7 days twice a day and stored in a cool 
room at 18.3°C. Dirty eggs or with any shell anomaly were discarded. Collected eggs 
were placed in a GQF® automatic incubator at 37.5 °C and 50-60 % humidity for 18 
days and then transferred to a GQF® hatcher at 36.9 °F and 60-70% humidity. Eggs were 
monitored once a day with regard temperature and humidity. 
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5.2.4 Liquid vitamin D3 source 
 A concentrated liquid vitamin D3 (Pure Life® Labs) containing 50,000 IU D3/ ml 
was used to supplement the increasing doses of cholecalciferol.  
5.2.5 Dietary treatments  
 Breeder and pullet-starter basal corn-soy vitamin D3-deficient diets were 
formulated using a customized mineral/vitamin premix without vitamin D3 and utilizing 
corn oil as the fat source (Table 23). NRC (1994) body weight (225 g) and feed 
consumption (485 g) data for leghorn-type chickens was used to estimate the increasing 
doses of vitamin D3 per kg of feed consumed over a 20-day period. Daily gavage 
treatments were based on estimated consumption of 0, 40, 80, 160, 200, 400, 800, 1,600 
IU D3/kg of feed consumed over the 20 day rearing period. The liquid source of Vitamin 
D3 was diluted in corn oil to yield a concentration of 77.6 IU D3/ml corresponding to the 
highest treatment dose (1,600 IU/kg) and then diluted again to yield the other treatments 
so that a daily constant dose was contained in 0.5 ml. The vitamin D3 treatments were 
separated in 20 daily doses and stored in a freezer at -28.88 °C until required.  
5.2.6 Feed and watering method 
 Both basal vitamin D3-deficient diets and water were offered ad libitum.  
5.2.7 Bone ash determination 
 
         The left tibia was dissected from selected birds at 21 day of age for bone ash 
determination to evaluate vitamin D3 activity. Muscle and cartilage were removed before 
being placed in 4 L of petroleum ether for 48-h at room temperature. Following this, 
tibias were dried for 24-h in a drying oven at 105°C. Finally tibias were ashed at 650°C 
for 23-h. Ash was evaluated as a percentage of the free-fat, dried bone weight. 
 77 
 
Table 23. Breeder and pullet starter experimental basal vitamin D-deficient diets 
Ingredient Breeder
1
 
% 
Pullet starter
2
 
% 
Corn 64.35 66.35 
Dehulled soybean meal 23.55 29.29 
DL-Methionine 0.17 0.13 
L-Lysine HCl 0.00 0.08 
Corn oil 0.00 0.00 
Limestone 10.00 1.72 
Monocalcium phosphate 1.31 1.58 
Salt 0.30 0.331 
Custom vitamin/mineral premix
3
 0.5* 0.5* 
1
Calculated nutritional content was as follow: crude protein 17%, metabolizable energy 2736.94 
kcal/kg, calcium 4.0 %, available phosphorus 0.38 %, methionine 0.43 %, methionine+cystine 
0.73 %, lysine 0.86%, tryptophan 0.19 %, threonine 0.63% arginine 1.09%, crude fat 2.68% and 
crude fiber 2.33% 
2
Calculated nutritional content was as follow: crude protein 20%, metabolizable energy 2900 
kcal/kg, calcium 1 %, available phosphorus 0.45 %, methionine 0.45 %, methionine+cystine 0.78 
%, lysine 1.10%, tryptophan 0.26 %, threonine 0.82% arginine 1.46%, crude fat 2.81% and 
crude fiber 2.6% 
3*
 Vitamin/mineral premix guaranteed analysis: Copper 2200ppm, Iodine 400 ppm, Iron 4,000 
ppm, Manganese 2.5%, Zinc 2.5%, Selenium  40 ppm, vitamin A 1,596,650 IU/kg and vitamin E 
7,964 IU/kg. Recommended inclusion level 5 kg/t to manufacture complete poultry feed. 
 
 
5.2.8 Dual X-ray absorptiometry (DEXA) 
The 96 Hy-line chicken carcasses were separated by treatment and identified by pen, and 
then stored in a freezer at -28.88°C. Two days before the DEXA scan the chicken 
carcasses were thawed and the feathers were removed by hand, and then stored in a 
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refrigerator at 5°C overnight.  
 Chickens were placed in supine position with their wings and legs at the sides of the 
body. The analysis was made using the GE Dual X-ray absorptiometry (DXA) scan located 
in the Applied Exercise Science Laboratory at Texas A&M University, and the GE small 
animal software which is specifically designed for animals <20 kg.  Total bone mineral 
content (g) was obtained.   
5.2.9 Statistical analysis 
         Data were subjected to repeated measures analysis using the GLM procedure of 
SPSS. Dietary treatments were used as a fixed factor. Means were separated by Duncan´s 
multiple range test. Statistical significance was accepted at p≤0.05. Bone ash assays data 
were analyzed using the pair correlation function of the same software. Broken-line 
regression was used to analyze the percentage bone ash using the “Nutritional Response 
Model Program” Version 1.01 from Gene Pesti and Dmitry Vedenov, University of 
Georgia. Each pen served as the experimental unit for performance and bone ash data 
analysis. 
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5.3 RESULTS 
5.3.1 Performance 
After 1 week on their respective treatments no significant (p>0.05) differences in 
weight gain, feed gain ratio, productivity index and mortality were observed in Hy-line 
chickens consuming increasing doses of cholecalciferol (Table 24). However, significant 
(p<0.05) differences were detected in body weight and feed weight ratio. Body weight 
for chickens consuming 300 IU D3/kg registered the lowest values while those 
consuming 2,009 IU D3/kg had the highest values when compared to the NC treatment.    
For the second week of the study, a significant (p<0.05) difference was found in 
body weight and weight gain between Hy-line chickens consuming the increasing doses 
of cholecalciferol (Table 25).  Birds consuming 145.6 IU D3/kg registered the worst 
weight gain and body weight while birds consuming 2,009 IU D3/kg registered the 
highest values for both parameters.  
No significant (p>0.05) differences in feed gain ratio, productivity index and 
mortality were observed in Hy-line chickens after 2 weeks consuming different 
concentrations of cholecalciferol. 
After 3 weeks being orally gavaged with increasing doses of cholecalciferol no 
significant (p>0.05) difference was found in feed gain ratio, feed weight ratio, 
productivity index and mortality among treatments in Hy-line chickens (Table 26). 
However, significant (p<0.05) differences were detected for body weight and weight gain 
with respect 62.3 and 145.6 IU D3/ kg. But, no significant difference was found when 
compared to the NC treatment.  
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Table 24. ANOVA Body weight, weight gain, feed gain ratio, feed weight ratio, productivity index and mortality in Hy-
line chickens after 1 wk of consuming 0, 62.3, 145.6, 242.2, 300, 525, 1,043 and 2,009 IU D3/kg. 
 IU D3/kg 
0 62.3 145.6 242.2 300 525.5 1043 2009 
BW 77.34±1.81cbd 73.50±3.06cbd 72.92±0.35cd 76.16±1.88cbd 70.92±1.06d 79.16±3.30abc 80.41±1.53ab 80.92±6.01a 
FI 0.062 0.056 0.062 0.060 0.054 0.067 0.068 0.069 
C-FI 0.062 0.056 0.062 0.060 0.054 0.067 0.068 0.069 
WG 32.34±2.35 28.34±1.88 28.09±0.12 31.67±1.64 25.42±0.82 34.09±2.00 34.92±3.65 35.58±8.13 
P-F:G 1.93±0.06 1.97±0.63 2.20±0.16 1.92±0.13 2.13±0.49 1.98±0.13 1.97±0.15 1.99±0.31 
F:W 0.81±0.1ab 0.76±0.07a 0.85±0.05ab 0.79±0.03ab 0.76±0.01a 0.85±0.04b 0.85±0.01ab 0.86±0.01b 
PI 57.06±2.77 53.13±3.96 47.36±3.58 56.81±5.35 47.54±1.83 57.21±6.33 58.55±5.83 59.59±13.68 
Mort 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 
a,b,c,d  Means within a row with no common superscript differ significantly (P<0.05). ± Standard deviation.     n= 2.   
Body weight (BW),weight gain , kilograms of feed consumed per bird (FI), cumulative kilograms of feed consumed per bird (C-FI), (WG), 
phase-feed gain ratio (P-F:G), feed weight ratio (F:W), productivity index (PI), Mortality (Mort)  
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Table 25. ANOVA Body weight, weight gain, feed gain ratio, feed weight ratio, productivity index and mortality in Hy-
line chickens after 2 wk of consuming 0, 62.3, 145.6, 242.2, 300, 525, 1,043 and 2,009 IU D3/kg.  
 
 IU D3/ kg 
0 62.3 145.6 242.2 300 525.5 1043 2009 
BW 135.50±1.41abc 125.75±10.25cd 118.00±1.41d 136.83±2.12abc 132.83±1.64bcd 145.08±10.72ab 149.42±3.41bab 151.58±11.43a 
FI 0.106 0.095 0.086 0.104 0.106 0.124 0.124 0.134 
C-FI 0.169 0.151 0.148 0.164 0.160 0.192 0.192 0.203 
WG 58.17±0.23bc 52.25±7.18cd 45.08±1.06d 60.67±0.23abc 61.92±2.70abc 65.92±7.42ab 69.00±1.81a 70.66±5.42a 
P-F:G 1.83±0.01 1.82±0.02 1.93±0.07 1.71±0.02 1.72±0.06 1.9±0.16 1.8±0.07 1.90±0.23 
F:W 0.79±0.01 0.75±0.03 0.73±0.02 0.76±0.01 0.80±0.05 0.86±0.04 0.83±0.01 0.88±0.10 
PI 52.86±0.29 49.18±4.64 43.74±2.08 56.93±1.48 55.19±1.35 54.81±8.91 59.19±1.23 57.47±11.15 
Mort 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 
a,b,c,d  Means within a row with no common superscript differ significantly (P<0.05). ± Standard deviation.     n= 2.   
Body weight (BW),weight gain , kilograms of feed consumed per bird (FI), cumulative kilograms of feed consumed per bird (C-FI), (WG), 
phase-feed gain ratio (P-F:G), feed weight ratio (F:W), productivity index (PI), Mortality (Mort)  
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Table 26. ANOVA Body weight, weight gain, feed gain ratio, feed weight ratio, productivity index and mortality in Hy-
line chickens after 3 wk of  consuming 0, 62.3, 145.6, 242.2, 300, 525, 1,043 and 2,009 IU D3/kg.  
 
 IU D3/kg 
0 62.3 145.6 242.2 300 525.5 1043 2009 
BW 219.33±2.12ab 202.42±20.62bc 178.92±2.24c 226.00±7.77ab 217.00±4.70ab 234.58±21.09a 240.83±5.89a 246.42±16.85a 
FI 0.129 0.159 0.117 0.155 0.162 0.177 0.179 0.182 
C-FI 0.298 0.311 0.266 0.320 0.323 0.369 0.372 0.386 
WG 83.83±0.70ab 76.66±10.37b 60.92±0.82c 89.17±5.65ab 84.16±3.06ab 89.50±10.36ab 91.42±2.47ab 94.84±5.42a 
P-F:G 1.54±0.50 2.11±0.45 1.93±0.01 1.74±0.06 1.93±0.07 1.98±0.02 1.96±0.14 1.93±0.18 
F:W 0.59±0.19 0.79±0.14 0.66±0.01 0.68±0.01 0.75±0.04 0.75±0.01 0.74±0.05 0.74±0.07 
PI 71.69±24.24 47.19±14.82 44.11±0.62 61.72±4.35 53.58±0.93 56.48±5.83 58.70±2.81 61.30±10.10 
Mort 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 
a,b,c,  Means within a row with no common superscript differ significantly (P<0.05). ± Standard deviation.     n= 2.   
Body weight (BW),weight gain , kilograms of feed consumed per bird (FI), cumulative kilograms of feed consumed per bird (C-FI), (WG), 
phase-feed gain ratio (P-F:G), feed weight ratio (F:W), productivity index (PI), Mortality (Mort)  
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A clear difference in body weight was observed in the Hy-line chickens after 20 
days consuming their respective concentrations of cholecalciferol (Figure 25). Poor 
growth and feathering was observed in those birds consuming low concentrations of 
cholecalciferol (0-242.2 IU D3/kg) with respect higher doses (1,043-2,009 IU D3/kg). 
 
 
 
Figure 25. Selected experimental subjects at 20 days of age.  
From left to right: 0 IU/kg, 300IU/kg and 2,009 IU/kg cholecalciferol. 
 
 
Average final body weight per pen (6 birds) of Hy-line chickens consuming 
increasing doses of cholecalciferol was used in the broken-line regression analysis 
(Figure 26). The breaking point in the ascending line of the graph corresponds to the 
estimated vitamin D3 requirement for growing chickens when performance is used to test 
the maximum response to different dietary levels of cholecalciferol. 
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Figure 26.  Average final body weight (g) per pen (6 birds) broken-line response to increasing 
concentrations of cholecalciferol (0, 62.3, 145.6, 242.2, 300, 525, 1,043 and 2,009 IU D3/kg). 
[y=Max +Rate constant*(Time to maximize-x)]. 
 
 
5.3.2 Bone ash 
The results of the percentage bone ash and total ash weight are presented in Figures 
27 and 28. Again, the breaking point of the ascending line of the graph corresponds to 
the calculated vitamin D3 requirement of growing chickens. 
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Figure 27.  Percentage bone ash broken-line response to increasing concentrations of 
cholecalciferol (0, 62.3, 145.6, 242.2, 300, 525, 1,043 and 2,009 IU D3/kg).  
[y=Max +Rate constant*(Time to maximize-x)]. 
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Figure 28.  Total tibia ash  broken-line response to increasing concentrations of cholecalciferol 
(0, 62.3, 145.6, 242.2, 300, 525, 1,043 and 2,009 IU D3/kg).  
[y=Max +Rate constant*(Time to maximize-x)]. 
 
 
5.3.3 Total body bone mineral content (BMC) DEXA scan 
 
The total body mineral content (g) of the scanned chickens is presented in Figure 
29. Chickens were scanned individually and the average BMC was calculated for each 
pen. The breaking point of the ascending line indicates the estimated vitamin D3 
requirement for growing Hy-line chickens.  
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Figure 29. Total body bone mineral content (g) broken-line response to increasing 
concentrations of cholecalciferol (0, 62.3, 145.6, 242.2, 300, 525, 1,043 and 2,009 IU D3/kg). 
[y=Max +Rate constant*(Time to maximize-x)]. 
 
 
Bivariate correlations between DEXA (BMC) versus final body weight (BW), 
percentage bone ash (PBA) and total tibia ash (TTA) were calculated to study the 
statistical relationships between criteria used to evaluate the vitamin D3 response. 
Calculated coefficients of correlations were 93% (BMC vs BW), 71% (BMC vs PBA), 
92% (BMC vs TTA) (Table 27). 
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Table 27. Bivariate correlations between the DEXA versus final body weight, total 
tibia ash and percentage bone ash.   
Variables Coefficient of Correlation p value 
 DEXA vs final body weight response 
BMC- BW 93% <0.001 
 DEXA vs percentage bone ash 
BMC-PBA 71% 0.002 
 DEXA vs total ash content 
BMC-TTA 92% <0.001 
  n= 16 per assay.  Bone mineral content (BMC), body weight (BW), percentage bone ash (PBA), 
total tibia ash (TTA)  
 
 
5.4 DISCUSSION 
The results of the present study indicate that percentage bone ash was not very 
useful to precisely determine the vitamin D3 requirement for growing leghorn chickens. 
The coefficients of determination for percentage bone ash and final body weight were 
21.35 % and 48.8 % respectively.  Contrary to our results, it has been stablished that the 
quantitative requirement of growing chickens for vitamin D is usually based on 
measurements of bone quality, such as bone ash content or incidence of rickets, which 
have been found to be more sensitive indicators than growth rate (Waldroup et al., 1963 
and Edwards et al., 1994). However, in agreement with the previous authors, when the 
percentage bone ash data from my study was expressed as total tibia ash, the coefficient 
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of determination improved to 64.46% providing the best model to predict the vitamin D3 
requirement.  
 In this study, the data obtained from the four criteria (final body weight, 
percentage bone ash, total tibia ash and BMC) used to evaluate the chickens response to 
increasing doses of cholecalciferol was subjected to broken-line regression analysis and 
the breaking points were estimated to be 758.2 IU/kg for 21-day body weight, 732.45 
IU/kg for percentage bone ash, 800 IU/kg for total tibia ash weight and 600 IU/kg for 
BMC.  This results support the hypothesis that the NRC (1994) vitamin D3 requirement 
of 200 IU/kg might be inadequate for modern poultry industry leghorn strains and higher 
levels may be needed to ensure maximum performance. In agreement with this, Heiman 
and Tighe (1942) reported that the vitamin D3 requirement for white-leghorn chickens 
was 500 IU/kg. Also, in more recent studies several authors suggest that higher amounts 
of vitamin D3 1000-3500 IU/kg are needed to support the growth rate of modern poultry 
strains (Kasim and Edwards, 2000, Ledwaba and Roberson, 2003, Whitehead et al. 2004, 
Khan et al., 2010). Contrary to our results, Baird et al. (1935) estimated the vitamin D3 
requirement for brown egg layers to be 180 IU/kg. McNaughton et al. (1977) found that 
198 IU/kg of cholecalciferol were enough for 3-week-old growing chickens when 
adequate (1%) Ca is contained in the diet. Baker et al. (1998) reported, in agreement with 
the NRC (1994) that 200 IU/kg D3 appeared to be adequate for maximal weight gain and 
bone ash in broiler chickens from 8-20 days post hatching when fed adequate levels of 
available P. Additionally, recent research in our laboratory estimated the vitamin D3 
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requirement to be 54.8 IU/kg to support growth and bone mineralization in young 
growing chickens in agreement with the NRC (1994) (Fowler et al., 2014).  
 High positive correlations were obtained for all parameters when compared with 
the bone mineral content (BMC) reported by the DEXA scan. Coefficients of correlation 
were 93%, 71% and 92% (r) for BMC versus body weight, percentage bone ash and total 
tibia ash, respectively. In agreement with these results, Swennen et al. (2004) compared 
the accuracy of the DEXA scan in Cobb broilers, using different measurements of body 
composition and bone, with the chemical carcass analysis, and found a strong correlation 
between BMC and total ash weight of 95% (r).  Schreiweis et al. (2005) evaluated bone 
integrity in Leghorn hens using the DEXA scan, and found a coefficient of correlation of 
85% (r) between BMC and excised bones. Contrary to our results, where percentage 
bone ash registered the lowest coefficient of correlation, Onyango et al. (2003) found a 
correlation between BMC and percentage bone ash of 92% (r) in 3-week-old Ross-308 
broiler chickens.   
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5.5 CONCLUSION 
The results of this study indicate that the effect of intensive genetic selection in the 
modern poultry industry have altered birds nutritional requirement for vitamin D3.  
My results suggest that higher amounts of vitamin D3 are required to promote 
growth and bone mineralization in leghorn-type chickens.   
Feeding 4 times the recommended NRC (1994) vitamin D3 requirement seems to 
be needed to ensure maximum performance and bone quality. 
My results indicate that percentage bone ash was not the best parameter to predict 
the vitamin D3 requirement in leghorn chickens. 
The Dual X-Ray Absorptiometry proved to be a useful tool for the evaluation of 
bone quality. However, further research has to be done in order to standardize protocols 
that will allow the accurate prediction of nutritional requirements.   
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6. SUMMARY 
 
Modern industry poultry strains are selected for rapid growth, high production and 
maximum feed efficiency.  It is probable that the intensive genetic selection over the past 
20 years have altered the nutritional requirements of modern poultry strains.(Havenstein 
et al., 2003, Schmidt et al., 2009) Therefore, it is necessary to re-evaluate their ability to 
respond to modern diets and feeding strategies.   
One consequence of the improvement in growth rate and feed efficiency is the 
persistent incidence of bone abnormalities, which are an important component of the 
birds welfare, and therefore, in general performance. Several leg disorders such as tibial 
dyschondroplasia (TD), rickets and angular bone deformities represent a major economic 
issue for the poultry industry. Sullivan (1994) estimated annual losses in the United 
States due to skeletal problems in broiler production around $80 to $120 million USD 
which adjusted to the annual inflation (U.S. Bureau of Labor Statistics) would represent 
$ 128,000,000 to 192,000,000 USD in 2014.  
Vitamin D is a term associated with a group of related steroid chemical compounds 
that possess antirachitic activity. The main role of vitamin D is the control of bone 
development by strictly regulating mineral absorption (Aslam et al., 1998).  There are 
two common forms, ergocalciferol (D2) and cholecalciferol (D3). Since D2 has about 10% 
the bioactivity of D3 for poultry (McDonald et al. 1995) D3 is used to supplement poultry 
feeds. The quantitative requirement of growing chickens for vitamin D3 is usually based 
on functional assessments using measurements of bone quality, such as bone ash content 
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or incidence of rickets, which have been found to be more sensitive indicators of 
requirements than growth rate (Waldroup et al., 1963, Edwards et al., 1994). The vitamin 
D3 requirement reported by the NRC (1994) is 200 IU/kg of feed for both growing 
broilers and leghorn strains. There is a big debate regarding the vitamin D3 requirement. 
Some authors, in agreement with the NRC (1994) support the 200 IU/kg of feed to be 
valid (Baker et al., 1998, Fowler et al., 2014). Other authors suggest that higher amounts 
of vitamin D3 (1,000-3,500 IU/kg) are needed to support the growth rate of modern 
strains (Kasim and Edwards, 2000, Ledwaba and Roberson, 2003, Whitehead et al., 
2004, Khan et al., 2010). Recent literature suggesting higher requirements for vitamin D3 
presume this to be due to changes in metabolism of the rapid growth modern poultry 
strains. 
Three experiments were conducted to better understand the effect of the intensive 
genetic selection in the nutritional requirements of modern poultry strains. In experiment 
one, broiler chickens where obtained from two commercial hatcheries, Sanderson Farms 
(Bryan, TX) or Cobb hatchery (Timpson, TX), and caged in a Petersime battery brooder. 
Broiler chickens were fed ad libitum a basal vitamin D3-deficient broiler starter diet with 
the objective of evaluating the variability in maternal deposition of vitamin D3 in the egg 
yolk. No significant (p>0.05) differences were found in the initial serum concentration of 
25-hydroxycholecalciferol (25-OH-D3) within sources of broiler chickens. Initial serum 
25-OH-D3 concentration was around 30 ng/ml which decreased linearly to 5 ng/ml over a 
10 day period. Maternal vitamin D reserves will deplete around day 10 regardless of the 
initial concentration in newly hatched chickens.  In the second experiment, newly-
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hatched broiler chickens were placed in a Petersime battery brooder, and blood samples 
were taken at different time points during a 24 h period to evaluate the dynamics of 
serum 25-OH-D3. A significant (p<0.05) linear increase in serum 25-OH-D3 was found 
over the 24 h exposure to the treatment diets. Finally, in experiment three, a total of 96 
Hy-line chickens were placed in a very controlled environment and a concentrated liquid 
form of cholecalciferol was directly gavaged in precise increasing amounts to re-evaluate 
the requirement of vitamin D3 of growing leghorn chickens.  The estimated requirement 
was 800 IU D3/kg of feed for maximum growth and bone mineralization.  
These experiments demonstrate the importance of having a strict control on the 
breeder´s diet to produce a vitamin D3-deficient chick. Additionally, the depletion rate of 
vitamin D3 is similar in broiler chickens obtained from different commercial hatcheries. 
This study also corroborates that the concentration of serum 25-OH-D3 is highly 
correlated with the antirachitic dietary source and level, supporting the hypothesis 
(Pettifor et al., 1977) that 25-OH-D3 is in fact a good marker to assess the status of 
vitamin D in poultry species. It also suggests the NRC (1994) estimated vitamin D3 
requirement of growing leghorn chickens is inadequate to support growth and bone 
mineralization of modern leghorn strains. 
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